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Characteristics of breast tumor stroma, including altered collagen architecture and 
increased stiffness, are known to contribute to tumor invasion and metastasis. However, the 
cellular and molecular mechanisms by which these changes occur are not fully understood. To 
address this question, we used a mouse genetic model to delete Discoidin Domain Receptor 2 
(DDR2) from mouse tumor stromal cells and interrogated breast cancer associated fibroblasts 
(CAFs) to determine the molecular events downstream of DDR2 action that may lead to changes 
in the tumor extracellular matrix (ECM). Our work revealed that the action of DDR2 in breast 
stromal cells is required for tumor lung metastasis but does not affect tumor growth or latency. 
Interestingly, stromal DDR2 action led to lengthened, thickened, and straightened collagen fibers 
while also stiffening the tumor. Tumor stiffness was found to be greatest at the invasive front of 
the tumor, closest to the tumor/stromal boundary; this finding was obliterated in tumor stromas 
without DDR2. Selectively studying CAFs ex vivo, we found that DDR2 promotes increased 
cellular contraction and traction force. Super-resolution microscopy analysis of focal adhesion 
complexes in CAFs revealed that DDR2 collagen binding facilitates focal adhesion maturation 
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and enhances integrin ß1 activation through recruitment of Talin11. We also find that DDR2 
regulates Rap1 activation, suggesting a mechanism by which Talin11 is activated downstream of 
DDR2 collagen binding. Taken together, these results identify DDR2 as a novel 
mechanosensing/mechanotransducing cell surface receptor that promotes tumor invasion and 
metastasis by acting in tumor stromal CAFs to control ECM remodeling, in part through 











Chapter 1: Introduction 
 
Breast cancer 
 Breast cancer is the leading cause of new cancer incidence in women in the United States, 
and the second leading cause of cancer related death. According to the American Cancer Society, 
prediction models estimate that there will be approximately 250,000 new cases of invasive breast 
cancer diagnosed and 40,000 breast cancer related deaths for women in 2017. While mortality 
has decreased over the past several decades due to improvements in detection and treatment, 
breast cancer will still lead to the deaths of 1 in 10 women within 5 years and approximately 1 in 
5 within 10 years. Additionally, incidence of breast cancer continues to rise in some populations, 
indicating that further research is still needed to determine how best to prevent, and, most 
importantly, to treat these patients (American Cancer Society, Cancer Facts & Figures, 2017).   
Breast cancer, in general, is believed to arise from acquired mutations in the epithelial 
cells lining the mammary gland or in their progenitors. These acquired mutations must, by 
definition, lead to deregulation of normal cell proliferation and resistance to cell death, among 
other characteristics (Hanahan and Weinberg, 2011). In the epithelial lining of the normal 
mammary gland, there are two epithelial cell layers, one luminal and one basal. These layers 
arrange themselves on a basement membrane, which separates the mammary epithelial cells 
from the surrounding stroma. The luminal epithelial cells face the lumen of the mammary gland, 
express cytokeratin 8 (K8), and are secretory, while the basal epithelial cells can be appropriately 
described as myoepithelial cells and are more elongated, contractile, and express cytokeratin 14 
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(K14) (Shehata et al., 2012). Breast cancer in humans progresses through a series of increasingly 
complex steps from atypical ductal hyperplasia, to ductal carcinoma in situ (DCIS), then invasive 
carcinoma, which is defined by tumor cells breaking through the basement membrane and 
invading into the surrounding stroma, and finally metastasis to distant organs (Fig. 1.1)  (Hu et 
al., 2008; Lerwill, 2004; Pinder, 2010). 
Breast cancers can be classified by a combination of histopathological and molecular 
analyses, the details of which will only be briefly touched on here. Histopathological analysis of 
breast cancers relies heavily on hormone receptor status for classification, ie- estrogen receptor 
(ER +/-), progesterone receptor (PR +/-), and human epidermal growth factor receptor-2 (HER-2 
+/-). A lack of these receptors is termed triple negative breast cancer (TNBC). More recently, 
molecular subtyping has complemented hormone receptor status classification and stratified 
breast cancers into four distinct subgroups; luminal A and luminal B, HER-2 overexpressing, and 
basal-like. Typically, luminal types are less aggressive than the HER-2 overexpressing or basal-
like subtypes, with basal-like bearing the worst prognosis (Fig. 1.2). TNBCs usually fall into the 
basal-like subtype. Basal-like or TNBC cancers do not lend themselves to receptor specific 
intervention and, therefore, are generally approached with less specific and more toxic 
chemotherapy treatments (Cancer Genome Atlas, 2012; Sorlie et al., 2001; Sorlie et al., 2003). 
Overall risk for the development of breast cancer has been ascribed to many factors which can be 
globally described as those intrinsic to the biology patient (BRCΑ1/2 mutation, increased breast 
density, young age of menarche or high age of menopause, African-American race, etc) and 
those that are more social or socioeconomic (obesity, low access to care, pregnancy, breast 





 Metastasis of breast tumors to distant organs is the cause of most breast cancer related 
mortality (Lobbezoo et al., 2015), with median survival after a diagnosis of metastasis being 2 to 
3 years (Cardoso et al., 2012). For tumor cells to metastasize, several things must happen. First, 
the tumor cells must be motile and capable of invading through the basement membrane and into 
an extracellular matrix comprised mostly of fibrillar collagens, primarily type I collagen, and 
fibronectin, among other matrix proteins. The cells invade the surrounding breast stroma either 
singly or as a collective, intravasate into the blood stream or lymphatics, survive in the blood 
stream or lymphatic system, ultimately extravasate, and seed other, non-random, organs (Fig. 
1.1). This process relies on the ability of tumor cells to navigate and survive outside of their 
normal environment, to resist exposure to the immune system, and to start proliferating again 
(Nguyen et al., 2009).  
The presence of tumor cells in the bloodstream (circulating tumor cells; CTCs) has been 
shown to be prognostic for poor outcomes (Cristofanilli et al., 2004) but can also be used to 
predict treatment response (Liu et al., 2009). Interestingly, CTCs have recently been shown to be 
more likely to result in metastases if they are circulating as collectives and also associated with 
cells expressing mesenchymal markers, suggesting that metastasis is not a tumor cell specific 
phenomenon but instead is a multicellular and multi-cell type process (Micalizzi et al., 2017; Yu 
et al., 2013). The totality of mutations or combinations of mutations that allow tumor cells to 
successfully metastasize are not entirely known, however transient acquisition of mesenchymal 
cell characteristics through the process of epithelial-mesenchymal transition (EMT) (Kalluri and 
Weinberg, 2009; Zhang et al., 2013), conditioning of a pre-metastatic niche in distant organs 
(Peinado et al., 2017), and the ability of a cell to undergo dormancy (Barkan et al., 2008; Lu et 
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al., 2011; Naumov et al., 2003) are all likely required for these relatively rare, when considering 
cell bulk in breast tumors, metastastic events to occur.   
In women, the most common sites of breast cancer are lungs, liver, and bone (Paget, 
1889; Weigelt et al., 2005). These metastases cause significant morbidity, including pathologic 
fractures at sites of bone metastasis, and are ultimately fatal. Breast cancer metastasis is unlikely 
to be cured once diagnosed, but recent improvement in treatment have prolonged patients’ 
progression free survival periods (Chia et al., 2007). Preventing these metastases from occurring 
by restricting tumor cells to the primary site continues to be one of the main goals of breast 
cancer metastasis research.  
 
Mammary stroma and changes during breast cancer 
Normal mammary glands are surrounded and supported by a basement membrane which 
is set within a matrix of extracellular matrix proteins and adipose tissue. Extracellular matrix 
proteins were once considered a structural, but inert part of any organ or organ system, however 
that understanding has dramatically changed in recent years. Breast ECM is known to play roles 
in cell migration, differentiation, and proliferation (Engler et al., 2006; Hynes, 2009) as well as 
breast development (Robinson et al., 1999; Wiseman and Werb, 2002), lactation, and involution 
(O'Brien et al., 2010; Schedin et al., 2004). The breast ECM protein pool largely consists of 
fibrillar collagens, proteoglycans/glycoproteins, and fibronectin (Lu et al., 2012). These proteins 
are large, multidomain, and contain binding sites for receptors, such as integrins and discoidin 
domain receptors, which cause downstream cellular signaling. ECM proteins also have binding 
sites growth factors, leading to the generation of biochemical sinks or gradients that affect cell 
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behavior (Hynes, 2009; Oudin and Weaver, 2016). Several cell types are found in normal 
mammary stroma, including fibroblasts, immune cells of various types, adipocytes, and 
endothelial cells. Matrix composition is maintained by a balance between matrix production and 
remodeling. In normal tissue, fibroblasts are finely tuned to maintain tensional homeostasis; they 
quickly respond to changes in stiffness, such as a wound, by secreting stromal proteins and  
matrix degrading proteins such as matrix metalloproteinases (MMPs) and a disintegrin and 
metalloproteinases (ADAMs) (Humphrey et al., 2014). These matrix degrading enzymes can be 
secreted by other cell types as well (Cathcart et al., 2015; Oudin and Weaver, 2016).  
 As breast cancer progresses to invasive carcinoma, tumor cells invade through the 
basement membrane and come into contact with stromal cells and stromal matrix proteins such 
as fibrillar collagens. This contact influences both the tumor cells and the stroma in a reciprical 
interaction termed tumor-stromal crosstalk. For example, tumor and immune cells release growth 
factors such as platelet-derived growth factor (PDGF) and transforming growth factor β1 (TGFb) 
which stimulate stromal fibroblasts to proliferate and become activated, leading to increased 
collagen deposition  in tumors (Lohr et al., 2001). In response, activated stromal fibroblasts 
secrete growth factors, ECM proteins, and proteases which influence tumor cell survival, 
invasion, and migration (Fig. 1.3) (Mueller and Fusenig, 2004). Breast cancer progression also 
promotes inflammation- responses from the innate immune system include increased 
macrophage, neutrophil, and dendritic cell infiltration, and derrangements in the adaptive system 
can lead to altered T cell responses which favor tumor progression (Garcia-Mendoza et al., 2016; 
Oudin and Weaver, 2016; Quintana, 2017; Zhu et al., 2014). CAFs typically secrete chemokines 
and cytokines which cause an immunosuppressive, leading to reduced immune surveilance and 
tumor cell escape. In return, immune cells secrete activating paracrine factors which stimulate 
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CAFs to increase secretion of ECM proteins and ECM modifying enzymes such as MMPs which 
increase matrix remodeling (Kalluri, 2016). 
In a disease state, the tightly controlled normal homeostasis of ECM dynamics can 
become markedly dysregulated in regard to protein production, matrix degradation, or overall 
fiber architecture. Tumors can be thought of as a chronic wound; the fibrotic or desmoplastic 
reaction that occurs in breast cancer is highly similar to granulation tissue found in healing 
wounds (Dvorak et al., 1984), however, since the wound cannot heal, some proteins typically 
only found in early wounds persist in cancer stroma (Mackie et al., 1987; Yeo et al., 1991). This 
phenomenon is not specific to to breast cancer, and similar ECM derangements are found in 
pancreatic cancer (Jiang et al., 2016; Laklai et al., 2016) among others.  
 
Collagen architecture in breast cancer 
 While many factors change in the stroma of breast tumors, one of the most dramatic is 
that of fibrillar collagen, especially type I. Like in other inflammatory diseases where one of the 
main hallmarks is fibrosis, breast cancer can result in local desmoplasia or fibrosis. In fact, this 
toughened tissue is often why patients are able to feel a lump in the breast which can be 
indicative of breast cancer. Normal breast tissue comes in a wide range of densities, from those 
that are primarily adipose tissue with minimal glandular components to those that are very dense 
in both collagen and glands. Importantly, women with mammographically dense breasts, or those 
in which breast density accounts for more than 50% of the tissue are at a four-fold increase in the 
risk of developing breast cancer of any type (Boyd et al., 2001; McCormack and dos Santos 
Silva, 2006). The stromal components of this mammographic density have been shown to consist 
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primarily of fibrillar collagens (Alowami et al., 2003; Guo et al., 2001). In addition, when 
women with dense breasts do get breast cancer, they are also at a greater risk of developing 
metastasis, independent of other factors including age, body mass index, and treatment type of 
initial tumor (Habel et al., 2004). In sum, these clinical correlations make the study of changes in 
breast stromal collagen and how they affect tumor progression extremely important, and much 
work has been accomplished regarding this question in recent years. 
 In addition to a simple increase in the amount of breast stromal collagen being significant 
to poor outcome (Provenzano et al., 2008a), the overall architecture of stromal collagen fibers 
has also been found to be extremely important. Features of collagen fibers such as increased 
length, increased width, and relative alignment have all been found to correlate with poor 
outcomes (Conklin et al., 2011; Provenzano et al., 2006). Second Harmonic Generation (SHG) 
analysis by two-photon microscopy of collagen fibers near the tumor-stromal boundary has 
allowed the development of a tumor associated collagen signature (TACS) which predicts tumor 
invasion (Provenzano et al., 2006) and patient survival (Conklin et al., 2011). The TACSignature 
is scored from 1-3 with TACS-3 being the most aggressive. TACS-1 is defined as dense collagen 
in the region of the tumor and TACS-2 as straightened fibers which appear to bound the tumor 
region. TACS-3 is indicative of collagen fibers which have been aligned perpendicular to the 
tumor surface (Provenzano et al., 2008a). These fibers have been shown to be sites of tumor 
invasion out of the primary site (Fig. 1.4) (Provenzano et al., 2008b), and the presence of any 
TACS-3 phenotype is prognostic for poor disease-free survival independent of other factors 
including tumor grade, hormone receptor status, and lymph node status (Conklin et al., 2011). 
These changes in collagen architecture in primary breast tumors have been attributed to an active 
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reorganization process (Levental et al., 2009), however the complete understanding of how these 
changes occur has yet to be elucidated.  
  
Matrix stiffness and cellular mechanosignaling 
As these changes in tumor stromal collagen occur and as breast tumor progresses, the 
overall stiffness of the tumor increases (Lopez et al., 2011). Increased stiffness in a tumor occurs 
through a variety of mechanisms, including an overall increase in collagen content, increased 
fiber thickness through crosslinking and remodeling, as well as changes in cellular contractility 
of stromal cells  (Paszek et al., 2005). Importantly, tumor stiffness has been shown to correlate 
with breast cancer invasion and aggressive cancer subtypes. Using atomic force microscopy 
(AFM) techniques, human breast tumor stiffness was found to be highest at invasive edges of 
human tumors, and both basal-like and HER-2 overexpressing types were found to be stiffer 
overall than either Luminal A or Luminal B types (Acerbi et al., 2015).  
Cells respond to mechanical forces in their environments through a process termed 
mechanosignaling. The process can split into two components, mechanosensing and 
mechanotransduction. Cells sense their physical environments through various membrane 
receptors, and these mechanical properties are transduced into downstream intracellular signaling 
events. In normal conditions, this process allows for the matrix homeostasis through responses to 
slackened or tightened stroma. For example, normal fibroblasts are tuned to operate at a 
particular stiffness. When that stiffness changes, eg- if tissue is wounded, the fibroblast produces 
more ECM proteins and pulls on the tissue, which, when combined with controlled proteinase 
activity, returns the tissue to its normal tension. When mechanosensing and mechanotransduction 
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goes awry in disease, this process can turn into a feed-forward loop of increasing tissue stiffness 
and matrix reorganization (Humphrey et al., 2014).  
Because cells generally sense the stiffness of their surroundings through membrane 
receptors and cellular contractility, stiffened environments cause a reciprical effect in cells that 
leads to increased intracellular tension (Lo et al., 2000). This effect in tumor cells and fibroblasts 
has been shown to be dependent on integrins linked to the cytoskeleton via focal adhesion 
complexes (Choquet et al., 1997) and actomyosin contractility (Matthews et al., 2006; 
Provenzano et al., 2008b; Zhou et al., 2017). In breast tumors, cancer associated fibroblasts 
(CAFs) have been shown to be the cell type responsible for the production of tumor ECM, and 
they also remodel and stiffen matrix (Calvo et al., 2013; Zhang et al., 2016). This suggests that 
CAF dependent matrix remodeling and matrix stiffening is a viable target for medical 
intervention in the treatment of breast cancer metastasis.  
  
Cancer-associated fibroblasts (CAFs) 
 Breast cancer associated fibroblasts are a subset of mammary fibroblasts which have 
become permanently activated. Normally, fibroblasts become transiently activated in response to 
stimuli such as wounds. When stimulated, they migrate into the wound, contract and close the 
wound, and secrete matrix proteins that eventually form a scar (Tomasek et al., 2002). However, 
these temporarily activated fibroblasts revert back to a quiescent state once the wound has 
healed. Since cancer is a wound that does not heal, CAFs cannot and do not revert back to a 
quiescent state (Kalluri, 2016). Though the population of CAFs in any given tumor are 
heterogenous, they generally express the markers for activation, including vimentin, fibroblast 
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activated protein (FAP), and α-smooth muscle actin (aSMA) (Calvo et al., 2013), with the most 
specific being FAP (Fig. 1.5) (Jacob et al., 2012). Importantly, CAF markers have been shown to 
be correlated to outcome and have been successfully targeted in a mouse study of TNBC, 
indicating that CAFs are a good candidate for therapeutic intervention. (Paulsson and Micke, 
2014; Takai et al., 2016).  
Several studies have been conducted to determine the origin of CAFs, and it appears that 
they may derive from multiple sources. The largest source is likely from permanent activation of 
resident fibroblasts, however de-differentiation from epithelial cells via epithelial-mesenchymal 
transition (Iwano et al., 2002; Petersen et al., 2003) contributes a small portion, as do those 
dervied from bone-marrow progenitors (Ishii et al., 2003). It is not known whether CAFs are a 
cancer specific phenotype or if they are the ultimate end result of any chronic wound. It is 
unknown how CAFs are maintained in breast tumors, but growth factor stimulation in an 
autocrine or paracrine manner (TGF-b and PDGF, for example) play roles (Calon et al., 2014; 
Elenbaas and Weinberg, 2001). It is certainly also likely that the desmoplastic and reactive 
stroma serves to further potentiate CAF phenotype propogation (Calvo et al., 2013; Zhang et al., 
2016).  
CAFs play many crucial roles in cancer progression and metastasis, both chemically and 
mechanically. In the same manner that tumor cells secrete paracrine factors that affect CAF 
activation, CAFs secrete factors which affect tumor cell migration and invasion (Fig. 1.5). In 
fact, CAFs can induce pre-malignant epithelial cells to become cancer when co-cultured, 
indicating that CAFs may also play a role in tumorigenesis (Bhowmick et al., 2004; Olumi et al., 
1999). Secreted factors such as hepatocyte growth factor (HGF) (De Wever et al., 2004; Grugan 
et al., 2010), TGF-ß (Potenta et al., 2008), and CAF-derived exosomes (Richards et al., 2017) 
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have all been shown to enhance tumor progression. Further, CAFs have immunomodulatory 
effects through numerous cytokines which have been shown to generally suppress the immune 
response to cancer, leading to prolonged survival and immunoescape of tumor cells (Kalluri, 
2016). 
Mechanically, CAFs affect tumor progression by altering the ECM through which the 
tumor cells travel via secretion of ECM proteins and matrix remodeling. Aberrant secretion of 
ECM proteins, especially fibrillar collagen, causes increased tissue fibrosis or desmoplasia, and 
this desmoplastic response is correlated with poor outcomes, as already discussed. Remodeling 
of matrix by CAFs through secretion of proteases such as matrix metalloproteinases (MMPs) and 
increased cellular contractility can cause matrix to become stiffened. Stiffened matrix causes 
breast tumor cells to become more proliferative (Paszek et al., 2005) and, in an integrin and FAK 
dependent manner (Provenzano et al., 2009), more invasive, suggesting that stiffened ECM 
allows cancer cells to more easily escape the primary site. Remodeled and aligned fibers in 
tumors act as highways for tumor cells (Provenzano et al., 2006), either singly or as a collective, 
away from a tumor, likely through a process known as durotaxis (Sunyer et al., 2016). Exactly 
how fibers become aligned in tumors is not yet known. Intriguingly, CAFs have also been found 
to lead cancer cells through matrix in CAF-remodeled tracks. Remodeling of matrix to create the 







Discoidin Domain Receptors 
 The Discoidin Domain Receptor (DDR) family consists of two members, DDR1 and 
DDR2. DDR1 exists in five isoforms due to alternative splicing, the most common of which is 
DDR1b, while DDR2 only has one isoform (Fig. 1.6). DDRs are single-pass transmembrane 
receptor tyrosine kinases (RTK) which, unlike all other RTKs, do not bind a soluble ligand but 
instead utilize native, triple-helical collagen as their ligand (Shrivastava et al., 1997; Vogel et al., 
1997). In addition to both DDRs binding fibrillar collagens I, III, and V (Konitsiotis et al., 2008), 
DDR1 also binds collagen IV (Vogel et al., 1997) and DDR2 also binds collagens II and X 
(Leitinger and Kwan, 2006; Leitinger et al., 2004). These collagen binding preferences reflect 
the tissue specificity of the DDRs; DDR1 is expressed in epithelial cells where it may come into 
contact with basement membrane collagen IV while DDR2 is expressed in mesenchymal cells 
where it is mostly in contact with fibrillar collagens. However, in disease DDR2 can be 
aberrantly expressed by epithelial cells (Zhang et al., 2013).  
DDRs are made up of several protein domains; an extracellular N-terminal DS domain 
where collagen binding occurs (Leitinger, 2003), followed by a DS-like domain, a long 
intracellular juxtamembrane domain, and an intracellular C-terminal kinase domain (Borza and 
Pozzi, 2014).  Unlike for most RTKs, the DDRs exist as dimers on the cell surface in the absence 
of ligand, and this dimerization is mediated by the long juxtamembrane domain (Kim et al., 
2014) and must bind collagen as either dimers or multimers. DDR activation kinetics are also 
unique in that they are extremely long, on the order of hours (Shrivastava et al., 1997; Vogel et 
al., 1997). It has been shown for DDR1 that receptor internalization occurs prior to receptor 
phosphorylation (Mihai et al., 2009), however it is not known if the same is true for DDR2.  
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Importantly, the binding site on collagen for the DDRs is distinct from that of integrins (Zeltz et 
al., 2014), indicating that DDR and integrin binding to collagen can occur simultaneously.  
 Though DDRs are expressed reciprocally in normal tissues, only DDR2 expression in 
breast cancer is correlated to decreased survival (Ren et al., 2013; Toy et al., 2015). To 
determine the role of DDR2 in normal tissues, mouse knockout lines were developed. DDR2 null 
mice are viable, however they are dwarfs and both males and females are sterile (Corsa et al., 
2016; Olaso et al., 2002). The dwarf phenotype was found to be due to reduced chondrocyte 
proliferation, and mutations in DDR2 were later found to also be present in a subset of human 
dwarfism termed spondylo-meta-epiphyseal dysplasia with short limbs (SMED-SL) (Bargal et 
al., 2009). In addition, DDR2 null mice have delayed wound healing due to reduced fibroblast 
proliferation and invasion (Olaso et al., 2011). DDR2 activation has also been shown to regulate 
matrix metalloproteinase expression, specfically it regulates MT1-MMP or MMP14, a 
transmembrane metalloproteinase which activates other MMPs that degrade collagen 
(Majkowska et al., 2017; Olaso et al., 2002; Xu et al., 2005; Zhang et al., 2013). Taken together, 
these findings indicate that DDR2 plays a role in stromal cells in matrix remodeling. It was 
recently shown that DDR1 mediates collagen contraction, an effect that was dependent on non-
muscle myosin IIA and DDR1 clustering (Coelho et al., 2017). It was not clear from this study 
whether DDR1 mediated collagen clustering was dependent or independent of integrin activity. 
 Upon collagen binding, DDR2 autophosphorylates at several tyrosine residues. Signaling 
downstream of DDR2 activation involves interaction with cytosolic signaling proteins carrying 
Src homology-2 (SH2) domains or phospho-tyrosine binding (PTB) domains (Fig. 1.5) 
(Valiathan et al., 2012). In the Longmore lab, DDR2 was identified as a regulator of the EMT 
factor Snail1. Collagen binding led to Snail1 nuclear accumulation and stabilization downstream 
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of Src and ERK2 phosphorylation (Zhang et al., 2013). DDR2 has also been shown to modulate 
integrin activation in a manner which promotes enhanced cell adhesion without affecting integrin 
expression levels (Xu et al., 2012). The mechanism by which DDR2 affects modulates integrin 
activity has not been elucidated. In addition, kinase independent functions of DDR2 have yet to 
be fully explored. 
 
DDR2 in breast cancer 
DDR2 has been implicated in a number of diseases including arthritis (Xu et al., 2005; 
Xu et al., 2010), cardiac development (Cowling et al., 2014), and several cancers including lung 
(Kobayashi-Watanabe et al., 2017) and breast. DDR2 is not expressed in normal breast epithelial 
cells, however it is aberrantly expressed in 71% of invasive ductal carcinomas biopsied . In this 
study, the Longmore lab showed that DDR2 activation stabilized Snail1 protein levels which 
promoted tumor cell migration and invasion and facillitated lung metastasis in a transplant model 
of breast cancer (Zhang et al., 2013). In addition, DDR2 depleted tumors had a less aggressive 
collagen signature (TACS 2/3) when compared to controls (Zhang et al., 2013), suggesting that 
DDR2 in tumor cells may either directly influence the remodeling of collagen fibers or indirectly 
affect the action of stromal cells in the remodeling of collagen fibers.  
 In an MMTV-PyMT genetic model of breast cancer in global knockout mice, DDR2 was 
found to be critical for metastasis without affecting tumor cell growth or latency. The Longmore 
lab went on to show that DDR2 in basal epithelial cells, rather than luminal epithelial cells is 
required for breast cancer metastasis. Further, a decrease in fibrosis at end stage and a shift to a 
more TACS 1/2 collagen pheotype was observed in the DDR2 knockout mice (Corsa et al., 
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2016). Importantly, in a reciprical transplant experiment, it was also shown that DDR2 is 
required in the host for lung metastasis (Fig. 1.7). Further, DDR2 in CAFs promoted tumor cell 
collective invasion, possibly in a paracrine manner (Corsa et al., 2016). It is not yet known 
exactly what role DDR2 plays in the various stages of metastasis, however there is evidence that 
DDR2 affects angiogensis (Zhang et al., 2014) and tumor invasion, suggesting that DDR2 may 
play a role in both tumor cells and stromal cells at the primary site.  
 
Integrins, focal adhesion complexes, and molecular mechanosignaling 
 Interestingly, DDR2 has recently been shown to affect the activation of the collagen 
binding integrins α1β1 and α2β1 (Xu et al., 2012). Integrins, in addition to being cellular 
adhesive receptors, have been shown to mediate signals from the extracellular environment to 
promote cell survival and cell migration (Hytonen and Wehrle-Haller, 2016; Kim et al., 2011). 
Integrins are heterodimeric transmembrane cell surface receptors which bind ECM proteins. 
Each integrin pair consists of one of 18 different α subunits, the most common of which is aV, 
and one of 8 different β1 subunits, the most common of which is β1. These α and β1 subunits 
combine across cell types in various iterations to form 24 different integrin pairs (Humphries et 
al., 2006). Each integrin pair has a distinct binding affinity for different ligands, including those 
for laminin, fibronectin, fibrinogen, and collagen, among others (Humphries et al., 2006). The 
collagen binding integrins all have the β1 subunit in common and combine with α1, α2, α10, or 
α11 to recognize the specific collagen peptide sequence GFOGER (Emsley et al., 2000; Knight 
et al., 2000). Integrin subunits consist of a large extracellular domain, a single pass 
transmembrane domain, and a short cytoplasmic tail (Kim et al., 2011).  
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Integrin activation is regulated by conformational changes of the extracellular domain. 
The extracellular domain can exist in a bent, inactive state, an extended but closed intermediate 
state, or an extended, open, and activated state. Only the activated state has high affinity for 
ligand (Fig. 1.8) (Luo et al., 2007). These conformational changes and activation can be induced 
in a bidirectional manner by transmission of force from ligand (outside-in) or through 
intracellular signaling culminating in talin1 binding to the β1 subunit cytoplasmic tail (inside-
out) (Kim et al., 2011; Puklin-Faucher and Sheetz, 2009). Either way, through pulling from 
matrix or talin1 binding and downstream contractility, integrin conformational changes are due 
to forces pulling the α and β1 subunits apart and the head domains open (Puklin-Faucher et al., 
2006; Puklin-Faucher and Sheetz, 2009). In addition to increases in affinity for ligand upon 
integrin activation, increases in avidity also occur after talin1 binding due to integrin clustering. 
Clustering of integrins allows for additional adhesions to the matrix, which strengthens 
attachments, and also creates a local increase in the concentration of actin linking proteins (ie- 
focal adhesion proteins) and signaling partners. The cytoplasmic tails of the integrin subunits 
have no inherent signaling ability and, thus, associate with signaling partners such as Src and 
focal adhesion kinase (FAK) to mediate downstream signaling events (Arias-Salgado et al., 
2003; Jahed et al., 2014). 
 Traction forces to the ECM are transmitted through integrins by linkages to the actin 
cytoskeleton through large, dynamic protein complexes called focal adhesions (Fig. 1.9). Focal 
adhesion complexes are made up several proteins arranged in prescribed layers and mediate 
mechanotransduction, adhesion, and signaling (Liu et al., 2015; Parsons et al., 2010). The 
defined layers from distal to proximal are the extracellular integrin adhesion layer, an integrin 
signaling layer, a force transmission layer consisting primarily of talin1 and vinculin proteins, 
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and actin regulatory and fiber layers (Fig. 1.10) (Kanchanawong et al., 2010). It was recently 
shown that talin1 is the primary regulator of focal adhesion size; when the authors shortened 
talin1 through mutation, focal adhesion z plane length was shortened accordingly (Liu et al., 
2015). This work identified the primary functional force transmission unit of a focal adhesion to 
be the integrin – talin1 – actin chain.   
Importantly, focal adhesion complexes are the large (microns), multimeric end result of 
maturation from nascent focal adhesion. Focal adhesion maturation and growth occurs linearly 
with applied force  (Hoffman et al., 2011; Puklin-Faucher and Sheetz, 2009; Roca-Cusachs et al., 
2013). Further, force sensitive proteins in addition to talin1 serve to enhance integrin β1 
activation, focal adhesion maturation, and mechanotransduction. Kindlins, for example, are 
essential to the activation and clustering of integrins (Ye et al., 2013). They bind integrin β1 
cytoplasmic tails in a similar manner, though different location, as talin1s (Jahed et al., 2014) 
and have been shown to be required for normal integrin β1 activation (Kahner et al., 2012). 
Further, kindlin2 knockout recapitulates integrin β1 knockout in mice (Montanez et al., 2008). 
Vinculin proteins are also required for normal mechanotransduction and signaling as well as 
essential for focal adhesion maturation (Jahed et al., 2014). 
 
Activation and regulation of Talin1 
 Talin1 is the main link between ECM binding integrins and the actin cytoskeleton, and is 
the critical mediator of inside out integrin activation. Integrins absolutely depend on talin1 for all 
of their functions, therefore, research into talin1 structure, function, and regulation has lead to 
many insights regarding cellular mechanosensing and mechanotransduction. Talin1 is a large 
18 
 
protein and contains two FERM domains in the N-terminal head domain for integrin β1 binding. 
The ability of talin1 to bind several integrins as well as several actin filaments and then also to 
dimerize promotes growth of focal adhesions and integrin activation. Talin1 exists in the cytosol 
as a closed protein, and is activated to an open conformation by binding to RIAM  (Klapholz and 
Brown, 2017; Lee et al., 2009). It is also mechanoresponsive in that it stretches when bound to 
integrin β1 and actin. This stretching exposes binding sites along talin1, including those for 
vinculin, which enhances adhesion maturation (Gingras et al., 2010). Talin1 activation appears to 
occur in two steps which may occur simultaneously; switching to an open conformation and 
recruitment to integrin adhesions. One proposed mechanism by which talin1 is activated and 
recruited is that protein kinase C (PKC) signaling activates Rap1-GTP. Rap1-GTP then recruits 
RIAM to the membrane, and RIAM binds to and recruits talin1 the membrane (Klapholz and 
Brown, 2017; Lee et al., 2009). RIAM prefers binding to fully folded talin1, however RIAM 
binding disrupts the closed conformation of talin1 (Lee et al., 2013). Therefore, recruitment of 
talin1 to membranes by Rap1-GTP bound RIAM and opening of talin1 conformation to allow 
integrin β1 binding likely occur simultaneously. While much work has gone into establishing the 
necessity of talin1 in integrin activation, it is not yet known how Rap1-GTP or PKC may be 


































Figure 1.1: Breast cancer progression and metastasis. 
Breast cancer originates in breast epithelial cells or their progenitors after a genetic alteration 
which releases the cells from normal growth and proliferation restriction. Hyperplasia progresses 
to DCIS and ultimately invades through the basement membrane into the stroma. This 
progression is accompanied by changes in the stroma, including stiffened matrix, activation of 
stromal cells, and inflammation. Downstream of these changes, cells are able to invade away 
from the primary site, enter the blood stream, and ultimately seed other organs. Adapted from 

































Figure 1.2: Time to metastasis and overall survival of breast cancer subtypes. 
Of the four clinical breast cancer subtypes, basal types and ERBB2+ (HER2+/TNBC) progress 
to metastasis faster (A) and lead to worse overall survival (B) than Luminal A or B subtypes. 




































Figure 1.3: ECM dynamics and tumor progression. 
As breast tumors progress, changes in ECM are effected at the same time. Overall collagen 
deposition increases, matrix stiffness increases, and fibers become aligned to the tumor surface. 
These changes are associated with local tumor invasion, aggressive breast cancer subtypes, and 
overall poor prognosis. A) Image demonstrating parallel fibers in a TACS-1 phenotype near a 
non-invading tumor. (B) Graphical representation of A. (C) SHG image demonstrating collagen 
fibers which are perpendicular to the tumor surface of an invading tumor, TACS-2/3 phenotype. 


























Figure 1.4: Characterization of the activation of cancer associated fibroblasts.  
(A) Quiescent fibroblasts are resting, non-active cells. They exist in equilibrium with 
surrounding stroma and can be activated by wounds, cytokines, or other stresses. 
(B) Wound-healing or temporarily activated fibroblasts increase their activity to become 
contractile, change cellular morphology, and increase secretion of matrix proteins, cytokines, and 
matrix degradation proteins to heal wounds. This state is reversible. 
(C) Permanently activated fibroblast such as cancer associated fibroblasts. These cells are highly 
secretory, rapidly proliferate, and induce tumor progression. This state is non-reversible.  




















Figure 1.5: Schematic representations of DDR1 and DDR2. 
Diagram depicting the five isotypes of DDR1 (DDR1b is the most common) and DDR2 proteins. 
DDRs are large type 1 transmembrane receptor tyrosine kinases that bind fibrillar collagen. The 
extracellular domain consists of a distal DS domain which mediates collagen binding and a more 
proximal DS-like domain. The DDRs have a large intracellular juxtamembrane domain which is 
required for dimerization. The cytoplasmic kinase domain is typical of RTKS. Tyrosine residues 
upon which the DDRs get phosphorylated as well as N- and O- glycosylation sites are indicated. 


















Figure 1.6: DDR2 in the stroma is required for lung metastasis, fibrosis, and aggressive 
collagen phenotype. 
(A, B) Reciprocal transplant of WT or DDR2 null MMTV-PyMT primary tumor cells into WT 
or DDR2 null syngeneic host. (A) Tumor latency was unchanged. (B) DDR2 is required in both 
the host and stroma for breast cancer lung metastasis.  
(C) Picrosirius red staining on tumor sections from WT and DDR2 null MMTV-PyMT tumors. 
(D) Quantification of Picrosirius red staining from (C). 
(E) SHG images of collagen organization in 10-13 week old WT and DDR2 null tumors. 
(F) Quantification of TACS-1 (curly fibers) versus TACS-2/3 (straight fibers) phenotype in each 
group.  
































Figure 1.7: Integrin activation occurs in several steps. 
Diagram depicting the three conformational states of integrins. (1) The bent, closed conformation 
is an inactive, low affinity state, (2) the intermediate state which is extended but closed is also 
inactive, and (3) the extended and open conformation which is active with high affinity for 































Figure 1.8: Focal adhesions mediate force transmission. 
Diagram depicting the forces on a single integrin β1 – talin1 – actin linkage. Focal adhesions 
grow in response to mechanical load. Integrins and talin1s are recruited to adhesions, and 
actomyosin contractility acts upon these adhesions to form stress fibers. Talin1 is the primary 





























Figure 1.8: Focal adhesion proteins are arranged in prescribed nanoscale layers. 
Focal adhesions are assembled in specific layers. The adhesion layer contains integrin proteins 
which bind extracellular matrix ligand. These integrin β chains are bound by signaling molecules 
near the cytoplasmic leaf of the plasma membrane, which transmit mechanical signals to the cell. 
Proximal to the signaling layer is the force transduction layer where talin1 and vinculin proteins 
are found. Talin1 and vinculin are both mechanically regulated by applied forces and serve to 
enhance the maturation of focal adhesions. Following the force transduction layer is that which 
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Chapter 2: Stromal DDR2 is required for 
breast cancer lung metastasis. 
 
2.1 Introduction 
 Breast cancer is the second leading cause of cancer related death in women, and, while 
some progress has been made, metastasis remains a significant problem for patients and 
clinicians. Several characteristics of breast tumor stroma are prognostic for worse outcomes, 
including mammographic density, or collagen content (Provenzano et al., 2008), matrix stiffness 
(Acerbi et al., 2015), and collagen fiber alignment (Conklin et al., 2011). Collagen alignment 
relative to the tumor boundary is particularly correlated with local tumor invasion; this alignment 
has been characterized by the development of a Tumor Associated Collagen Signature (TACS) 
whereby a score of TACS 1 indicates a benign stroma and a score of TACS 2/3 indicates an 
aggressive stroma (Conklin et al., 2011; Provenzano et al., 2006). It is not yet fully known how 
these changes in tumor stroma occur. 
 Previous work in the Longmore laboratory identified Discoidin Domain Receptor 2 
(DDR2) as a regulator of the EMT transcription factor Snail1. DDR2 activation was found to 
lead to nuclear accumulation and subsequent stabilization of Snail1 protein in a Src/ERK2 
dependent manner. The stabilization of Snail1 promoted migration and invasion of breast cancer 
cells and facilitated lung metastasis in a transplant model of breast cancer (Zhang et al., 2013). 
Importantly, the tumor associated stroma was also found to be affected by DDR2 in tumor cells; 
DDR2 activity promoted a TACS 2/3 aggressive phenotype, though the mechanism by which 
this change occurs was not elaborated.  
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 DDR2 is a unique receptor tyrosine kinase in that it binds fibrillar collagen rather than a 
soluble ligand. Full activation of the receptor takes several hours, another unique aspect when 
compared to other RTKs (Shrivastava et al., 1997; Vogel et al., 1997). Activation of DDR2 
occurs by phosphorylation of several tyrosines in the cytoplasmic tail, which recruits signaling 
partners bearing Src homology-2 (SH2) or phosphotyrosine binding (PTB) sites (Valiathan et al., 
2012). DDR2 is not normally expressed in epithelial cells, however it has been found to be 
expressed in 71% of invasive ductal carcinomas (Zhang et al., 2013). High expression of DDR2 
in breast tumors was also found to correlate with the triple negative breast cancer subtype and 
decreased overall survival when compared with low DDR2 expressing breast cancers (Toy et al., 
2015). DDR2 has been shown to have roles in wound healing, angiogenesis, and cell migration 
and invasion.  
 To determine the cellular role of DDR2 in breast cancer metastasis, a conditional allele 
was generated in the Longmore lab. This allele in combination with β1 actin-Cre generated 
global null DDR2 knockout mice (Corsa et al., 2016). DDR2 null mice are dwarfs due to 
defective chondrocyte maturation (Bargal et al., 2009) and are also sterile due to defects in 
spermatogenesis (Kano et al., 2010) and ovulation (Matsumura et al., 2009). Crossing DDR2 null 
mice to MMTV-PyMT generated tumor bearing mice, which, at end stage had significantly 
fewer lung metastases than wild type controls without affecting either tumor growth or latency. 
The cellular role for DDR2 was further parsed out by using MMTV-Cre to target luminal 
epithelial cells and K14-Cre to target basal epithelial cells. In this experiment, it was found that 
DDR2 in luminal epithelial cells had little effect while DDR2 in basal epithelial cells was 
required for metastasis (Corsa et al., 2016). In addition to lung metastases, the tumor ECM was 
also analyzed. Global DDR2 deletion reduced fibrosis while specific deletion in luminal or basal 
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epithelial cells did not. Further, a less aggressive collagen phenotype (TACS1) was more 
predominantly found in DDR2 global null tumors. Since stromal cells, including fibroblasts and 
immune cells have been implicated in fibrosis, a reciprocal transplant experiment was also 
performed to determine the contribution of DDR2 in the host – when wild type tumor cells were 
transplanted into a DDR2 null host, lung metastases were significantly reduced, indicating that 
DDR2 in the host is also required for metastasis (Corsa et al., 2016). The cellular and molecular 
mechanisms for this effect were not determined.   
 In this study, we sought to determine the breast tumor stromal role for DDR2 in breast 
cancer metastasis. We used FSP1-Cre to delete DDR2 from stromal cells in an MMTV-PyMT 
model of breast cancer, and, in this setting, we increased the specificity of DDR2 deletion from 
the entire host. We found that DDR2 is required in stromal cells for breast cancer metastasis 
without affecting tumor growth or latency. Further, we show that stromal DDR2 affects ECM 




FSP1-Cre targets breast tumor stromal cells. 
To test the effect of DDR2 in mammary tumor stroma, specifically cancer associated 
fibroblasts (CAFs), on breast cancer metastasis, we utilized the previously described conditional 
DDR2 flox allele (Corsa et al., 2016) in combination with the FSP1-Cre transgene in an MMTV-
polyoma middle T (PyMT) model of breast cancer. We chose this model because MMTV-PyMT 
mice develop multifocal primary tumors which progress from mild hyperplasia to invasive 
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adenocarcinoma in a manner which resembles human breast cancer. Additionally, tumors 
develop on a predictable timescale with robust metastasis to the lungs and are hormone 
independent (Guy et al., 1992; Schaffhausen and Roberts, 2009).  
At present, there are no promoter-Cre transgenes to selectively target CAFs, however, 
there are those which target CAFs as well as other cells. Therefore, we initially chose to evaluate 
two which have been used by other groups to target fibroblasts, FSP1-Cre and αSMA-Cre 
(Bhowmick et al., 2004; Cheng et al., 2005; LeBleu et al., 2013; Wu et al., 2007). Neither was 
expected to be absolutely efficient or specific. To determine which to choose, we utilized the 
ROSA-LSL-TdTomato reporter allele in early (10-11 week) MMTV-PyMT tumors and 
quantified the percent of TdTomato positive cells co-staining with various stromal cell markers 
(Fig. 2.1a). We found that TdTomato expression in FSP1-Cre mice was restricted to cells which 
express FAP (85%) while not expressed in K14 positive basal epithelial cells (~4%), K8 positive 
luminal epithelial cells (~0%), or CD31 positive endothelial cells (~0%) (Fig 2.1b). Further, the 
cells that express TdTomato lie in the matrix between epithelial tumor clusters and have a 
spindle shape morphology, indicating a cell of mesenchymal origin. In contrast, αSMA-Cre was 
expressed by few stromal cells overall, did not co-stain well with FAP positive cells, and was 
found, in some cases, to be expressed in cells within the tumor (Fig. 2.1c). Though the majority 
of FSP1-Cre expressing cells co-stain for CAF markers, it is also expressed in CD45 positive 
cells. Of the cells that express TdTomato in the FSP1-Cre; ROSA-LSL-TdTomato; MMTV-
PyMT mice, only 15-20% of them were CD45 positive, however, of the CD45 positive cells, 
nearly 90% were TdTomato positive (Fig 2.1b). 
Importantly and in contrast to DDR2 global null mice (Corsa et al., 2016; Olaso et al., 
2002), FSP1-Cre; DDR2 fl/fl mice are fertile and of normal size, further indicating the relative 
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restriction of FSP1-Cre expression (Fig 2.2a). Additionally, genotyping of total tumor tissue and 
Western blot analysis of DDR2 expression in CAFs isolated from FSP1-Cre; DDR2 fl/fl; 
MMTV-PyMT mice showed recombination of the DDR2 locus and total deletion of DDR2 
protein expression, respectively (Fig. 2.2b and Fig. 2.2c). Thus, these data indicate that FSP1-Cre 
is robustly expressed in stromal CAFs and is functioning to delete DDR2 in these cells.  
 
Stromal DDR2 is required for breast cancer lung metastasis 
To determine whether stromal DDR2 is required for breast cancer lung metastasis, we 
generated FSP1-Cre; DDR2 fl/fl; MMTV-PyMT mice and allowed them to develop tumors until 
end stage (2 cm maximum individual tumor size). DDR2 fl/fl; MMTV-PyMT or DDR2 fl/+; 
MMTV-PyMT littermates were used as wild-type controls and all mice analyzed were greater 
than 90% FVB strain. DDR2 deletion in the stroma did not affect overall tumor burden nor 
tumor latency, ie- time to end stage (~14 weeks) between groups (Fig. 2.3a, b). There was, 
however, a dramatic reduction in the number of lung metastases in FSP1-Cre; DDR2 fl/fl; 
MMTV-PyMT mice when compared to WT; MMTV-PyMT controls (Fig. 2.3c). These data 
indicate that stromal DDR2 expression has no effect on overall primary tumor growth but that it 
is necessary for breast tumor metastasis to the lung. 
 
Stromal collagen characterization. 
Because we had previously demonstrated that DDR2 global null mice have a less 
aggressive collagen phenotype (TACS 1 rather than TACS 2/3), we wanted to determine whether 
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there was a difference in extracellular matrix content or organization in the FSP1-Cre; DDR2 
fl/fl; MMTV-PyMT mice. To do this, we first performed histological analysis and stained early 
(10-11 week) tumors with Picosirius Red or Trichrome to visualize collagen fibers (Fig. 2.4a; 
quantified in Fig. 2.4b). We also quantified hydroxyproline content (an amino acid specific to 
collagen protein) in these tumors by a colorimetric biochemical assay (Fig. 2.4c). In contrast to 
earlier studies in our lab performed on end stage tumors, no differences in overall fibrosis was 
found in FSP1-Cre; DDR2 fl/fl; MMTV-PyMT tumors. These data suggest that stromal DDR2 
does not function to increase total fibrosis in early MMTV-PyMT tumors. 
 Characteristics of collagen fiber architecture, including parallel fiber orientation and 
increased fiber thickness, in tumor stroma is correlated to poor outcomes (Conklin et al., 2011). 
To determine if there was a difference in collagen architecture in FSP1-Cre; DDR2 f/f; MMTV-
PyMT tumors, we specifically visualized collagen fibers by second-harmonic generation (SHG) 
using two-photon microscopy in early tumors (10-11 weeks). These images of early tumors were 
scored for TACS signature as previously described (Provenzano et al., 2006). The collagen 
phenotype in FSP1-Cre; DDR2 fl/fl; MMTV-PyMT tumors was predominantly TACS1 (thin, 
curly fibers), while the collagen architecture in WT tumors was predominantly TACS 2/3 (thick, 
straight fibers) (Fig. 2.5a, b). Fibers in each group were further analyzed by CT-FIRE software 
developed at the Laboratory for Optical and Computational Imaging (LOCI) in Madison, 
Wisconsin. WT; MMTV-PyMT tumors were found to have significantly longer collagen fibers 
than FSP1-Cre; DDR2 fl/fl; MMTV-PyMT tumors (Fig. 2.5c).  
To get a more specific view of collagen fibers, we stained tumors with ruthenium red and 
tannic acid and subjected them to Focus Ion Beam Scanning Electron Microscopy (FIB-SEM). 
This technique allows for SEM resolution while milling through a sample to generate a 3D 
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reconstruction of fibers in a tumor. Similar regions of interest between samples were chosen 
adjacent to the tumor – stromal boundary. In wild type stroma (Fig 2.5d left), thick fibers and 
many cables of collagen can be seen crossing the tumor boundary, while in DDR2 global null 
stroma, fibers are thin, wispy, and sparse (Fig. 2.5d right). Images have been pseudocolored to 
indicate density of signal.   
 
Stromal DDR2 affects mechanical properties of tumors. 
 Increased extracellular matrix stiffness has been shown to correlate with increased tumor 
aggression and poor outcomes (Acerbi et al., 2015). This increased stiffness, specifically near 
tumor boundaries causes increased tumor cell invasion away from the primary tumor and tumor 
progression (Butcher et al., 2009). High intratumor tension or stiffness can be due to increased 
collagen deposition (Provenzano et al., 2008) and/or increased collagen crosslinking (Schedin 
and Keely, 2011).  
 To determine if the change in TACS phenotype in FSP1-Cre; DDR2 fl/fl; MMTV-PyMT 
tumors caused a change in tumor stiffness, we used atomic force microscopy (AFM) to 
interrogate flash-frozen, unfixed tumors from 10-11 week old mice. In order to avoid bias of a 
nano-scale tip on an AFM cantilever, we used cantilevers with a 5 um borosilicate glass sphere 
affixed to the tip (NovaScan). This allowed for a more general representation of the stiffness in 
any area in the tumor. Nuclei were stained with propidium iodide and force maps (50 um x 50 
um) of indentations were taken either in the tumor core or at the tumor – stromal boundary (Fig. 
2.6a). Results indicate that WT tumors are stiffer overall (Young’s Elastic Modulus (E) of 0.440 
kPa) than FSP1-Cre; DDR2 fl/fl; MMTV-PyMT tumors, which had an elastic modulus of about 
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0.300 kPa (Fig. 2.6b, c). These stiffness measurements on flash-frozen WT; MMTV-PyMT 
tumors agree with other groups’ findings (Lopez et al., 2011). Further, when regions of the tumor 
were segregated, data indicate that, like reported human tumors (Acerbi et al., 2015), WT; 
MMTV-PyMT tumors are stiffer at the tumor – stromal boundary (E = 0.452 kPa) than in the 
tumor core (E = 0.323 kPa) (Fig. 2.6d). In contrast, FSP1-Cre; DDR2 fl/fl; MMTV-PyMT 
tumors are of similar stiffness throughout (Edge; E = 0.239 kPa and core; E = 0.314 kPa) (Fig. 
2.6e). Results are quantified in Figure 2.6f. Together, these results indicate that DDR2 in the 
mammary tumor stroma affects the mechanical properties of tumors and promotes the formation 
of a gradient of increasing stiffness from the tumor core to the tumor – stromal boundary.  
  
2.3 Discussion 
Breast cancer metastasis is the leading cause of cancer related deaths in women in the 
United States, regardless of breast cancer subtype at diagnosis (American Cancer Society). The 
metastatic cascade begins when tumor cells escape from the primary site, are able to intravasate, 
survive in the blood stream as CTCs, extravasate, and seed distant organs (Butcher et al., 2009). 
Understanding these various steps may uncover new ways to intercede and prevent metastasis in 
the future. The Longmore lab has shown that DDR2 in tumor cells has marked effects on breast 
cancer metastasis, promoting not only cell invasion but also stromal changes which promote 
cancer progression (Corsa et al., 2016). In that study, DDR2 was shown to be most important in 
K14 positive basal epithelial cells, and, while the non-breast cancer compartment was explored 
in a reciprocal transplant model utilizing DDR2 global null mice, the role for DDR2 in stromal 
cells was not established.  
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In this study, we show that DDR2 action is required in stromal cells for breast cancer 
lung metastasis, and further show that there is no effect of stromal cell DDR2 on tumor growth 
or latency (Fig. 2.3). We use the stromal specific FSP1-Cre in combination with the DDR2 
conditional flox allele previously generated in the lab to target stromal cells in an MMTV-PyMT 
model of breast cancer. FSP1-Cre is expressed primarily in cancer associated fibroblasts (CAFs) 
as demonstrated by co-expression of ROSA-LSL-TdTomato (driven by FSP1-Cre) and FAP 
staining in cells that lie within breast tumor matrix (Fig. 2.1). In contrast to DDR2 global null 
mice, FSP1-Cre; DDR2 fl/fl mice are normal size and fertile, further supporting the restricted 
expression of FSP1-Cre and indicating that DDR2 in FSP1-Cre expressing cells is not required 
for skeletal growth, spermatogenesis, or ovulation (Fig. 2.2). Some of the cells which express 
FSP1-Cre are CD45 positive, indicating that a subset of cells of hematopoietic origin is also 
partially targeted in this model. CAF populations are extremely heterogeneous, and groups have 
shown that bone marrow derived CAFs and CAF precursors can and do express CD45 
(McDonald et al., 2015), so it is possible that the co-expressing FSP1-Cre/CD45+ cells are CAFs. 
It is more likely, however, that these cells are macrophages (Osterreicher et al., 2011). More 
work needs to be done in the future to determine the role of DDR2 in immune cells on breast 
cancer lung metastasis.  
Accumulation of collagen in breast stroma has been shown to be prognostic for poor 
outcomes. Despite the fact that a decrease in fibrosis was seen in previous studies of DDR2 
global null mice, no change in fibrosis or total collagen content as assessed by hydroxyproline 
assay was found in FSP1-Cre; DDR2 fl/fl; MMTV-PyMT tumors (Fig. 2.4). Tumor – stromal 
crosstalk and CAF – immune crosstalk are well established phenomena that can promote or 
inhibit the progression of cancer (Kalluri, 2016). While it is widely accepted that stromal 
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fibroblasts produce the majority of ECM proteins, they are influenced by paracrine factors from 
surrounding stromal cells and tumor cells (Papageorgis and Stylianopoulos, 2015). It is possible 
that tumor – stromal or CAF – immune crosstalk in the DDR2 global null mouse is impaired in a 
manner that depends on DDR2 action, which leads to reduced overall fibrosis in that model but 
not in FSP1-Cre; DDR2 fl/fl mice. This would suggest that DDR2 is not required on CAFs to 
respond to signals which increase ECM protein production but may be required in other cells to 
induce factors which promote fibrosis.  
The action of DDR2 in stromal cells was essential for the formation of an aligned, 
aggressive (TACS-2/3) collagen matrix in an MMTV-PyMT genetic model of breast cancer. 
Second harmonic generation analysis of tumors showed that FSP1-Cre; DDR2 fl/fl; MMTV-
PyMT mice primarily have curly, thin fibers rather than straight, thick fibers (Fig 2.5a,b). 
Further, DDR2 in stromal cells contributes to the formation of an increasing stiffness gradient 
leading away from the primary site. AFM data demonstrate that FSP1-Cre; DDR2 fl/fl; MMTV-
PyMT tumors are equally compliant throughout tumor and stromal regions while WT; MMTV-
PyMT tumors demonstrate increasing stiffness as one moves from the tumor core to the tumor – 
stromal boundary (Fig. 2.6f). Since cells tend to migrate up a stiffness gradient by durotaxis (Lo 
et al., 2000), it is possible that tumor cells do not metastasize in this model because they are 
unlikely to migrate away from the primary tumor due to the absence of a stiffness gradient. 
Characteristics of tumor matrix collagen fibers have been shown to lead to increased local 
invasion as well as to be prognostic for poor outcomes (Provenzano et al., 2006; Provenzano et 
al., 2009; Provenzano et al., 2008). Whether the increase in stiffness in vivo is solely due to 
increases in collagen fiber characteristics such as increased width and alignment or if cellular 
characteristics such as increased contractility contribute remains to be seen. We show changes in 
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tumor stromal alignment and stiffness without a change in total collagen content or fibrosis, 
suggesting a new model by which stromal remodeling separately from collagen deposition 
increases breast tumor stiffness and promotes cancer progression.  
In conclusion, we have identified a subset of stromal cells, likely CAFs, in which DDR2 
is required to form stiffened, aligned collagen matrix without affecting overall collagen 
deposition. This change in tumor stroma is correlated to a significant decrease in lung metastases 
and suggests that both a stiffness gradient and thick, aligned fibers facilitate tumor cell escape 
from the primary site.  
 
2.4 Materials and Methods  
Mouse genetic tumor studies 
The conditional DDR2 flox allele was generated as previously described (Corsa et al., 2016). 
This allele was crossed to FSP1-Cre and MMTV-PyMT mice to generate FSP1-Cre; DDR2 fl/fl; 
MMTV-PyMT mice. Wild type littermates were used as controls. We received the FVB/n FSP1-
Cre mice as a generous gift from the Werb laboratory (San Francisco, CA). Tumor bearing mice 
were monitored weekly until end stage (2 cm single tumor). The mice were then euthanized and 
tumors and lungs collected. All mice analyzed were >90% FVB/n strain. 
Immunofluorescence 
Tumors were dissected away from the skin and then cut into <1cm pieces to allow efficient 
fixation. Tumors were fixed overnight in 10% neutral buffered formalin and then equilibrated in 
30% sucrose overnight at 4 degrees. Equilibrated tissues were embedded in OCT and 
61 
 
cryosectioned at 5-10 um per section. Sections were post-fixed in 4% paraformaldehyde for 15 
min, permeabilized in 0.1% Triton X-100 for 5 min, and blocked in 5% goat serum for 1 hour at 
room temperature with washes in 1X PBS in between each step. Primary antibodies were 
incubated overnight at 4 degrees. Sections were then washed twice with 1X PBS and secondary 
antibody added for 1 hour at room temperature. Sections were then washed four times in 1X 
PBS, mounted in VectaShield with DAPI (VWR, 101098-044), and sealed with nail polish. 
Images were taken on an inverted Nikon epifluorescence microscope. Brightness and contrast 
adjustment as well as co-staining quantification was done manually in ImageJ.   
Lung metastasis analysis 
Lungs were fixed overnight in 10% neutral buffered formalin and then embedded in paraffin. 
Three 5 um sections were taken 200 um apart per lung and stained with hematoxylin and eosin. 
Metastases were counted in all lobes and documented as average number of total lung 
metastases. 
Western blotting 
Cells were lysed in 1X RIPA buffer supplemented with 1mM PMSF, 1mM sodium vanadate, 
1mM sodium fluoride, and 10 ug/ml each aprotinin and leupeptin. Lysates were sonicated twice 
for 30 seconds and centrifuged at 14,000 RPM, 10 min. Cleared lysates were separated by SDS-
PAGE, transferred onto PVDF membrane, and blocked for 1 hour at room temperature in 5% 
non-fat dry milk, 1X TBS-0.5% Tween. Membranes were incubated in primary antibody 
overnight at 4 degrees with gentle agitation, washed twice with TBS-0.5% Tween, and incubated 
with anti-mouse or anti-rabbit HRP secondary antibody for one hour at room temperature. 
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Membranes were then washed four times with TBS-0.5% Tween and developed with ECL 
(Pierce, 32106). 
Mouse Genotyping 
 Mouse tails were cut with a clean razor blade (~2 mm) and bleeding stopped with styptic 
powder. DNA was extracted and PCR run using KAPA Biosystems HotStart PCR (KK5621). 
Hydroxyproline quantification 
 Non-necrotic tumor tissues were dissected away from the skin and non-tumor tissue 
removed. The samples were dried overnight in a lyophilizer and then hydrolyzed in 6N HCl 
(Thermo Fisher Scientific P24308) at 103-106 degrees Celsius for 48 hours. Samples were then 
re-dried in a lyophilzer and resuspended in water. Total protein and hydroxyproline were 
quantified separately. Total protein amount was assayed by adding 100ul of working solution 
(245mg ninhydrin (Sigma 151173), 9ml ethylene glycol, 4.8m 4N sodium acetate, 0.3ml SnCl2 
(100mg/1mL ethylene glycol)) to 5uL of resuspended hydrolyzed protein, baked at 85 degrees 
Celsius for 10 minutes, and then read at 575nm on a plate reader. Standard curve generated using 
Pickering #0125056H. Hydroxyproline was assayed by adding to 50 ul of sample, 100 ul of 
chloramine T at room temperature for 20 min, then adding 100ul Erlich’s solution at 65 degrees 
Celsius for 20 min. The plate was then read at 550nm on a plate reader. Standard hydroxyproline 






Second Harmonic Generation and TACS score 
 Tumors from 10-12 week old mice were dissected and fixed in 10% neutral buffered 
formalin overnight at room temperature. They were then embedded in paraffin and sectioned in 
5-10um sections. In some cases, sections were stained with H&E, picosirius red, or trichrome 
stain prior to SHG imaging. Prior staining has no effect on SHG signal. Images were acquired on 
a Zeiss LSM 880 Airyscan confocal microscope using an inverted, motorized Zeiss Axio 
Observer Z1 frame. Two-photon images were collected at 880nm, using non-descanned detectors 
set to 440nm for SHG. Three to four z-stacks were acquired (step size 2 um) per tumor. The z-
stacks were compressed and TACSignature was scored by three blinded reviewers as TACS-1 
(curly fibers) or TACS-2/3 (straight fibers) as previously described (Corsa et al., 2016; 
Provenzano et al., 2006). 
FIB-SEM 
Mice were perfused with pre-warmed, 37-degree, Ringer’s solution (155mM NaCl, 3mM KCl, 
2mM CaCl2, 1mM MgCl2, 3mM NaH2PO4, 5mM HEPES, pH 7.4, 10mM glucose) for 2 min and 
then for 5 min with pre-warmed, 37-degree fixative (2.5% glutaraldehyde, 2% 
paraformaldehyde, 0.05% ruthenium red, 0.2% tannic acid in 0.15M cacodylate). Tumors were 
then dissected out and placed in fixative for 15min at 37 degrees, then 4 degrees overnight. 
Samples were embedded in resin and scanned by FIB-SEM. 
Atomic Force Microscopy 
Non-necrotic 10-12 week tumors were gently dissected away from the skin and flash frozen in 
OCT. Tumors were sectioned at 20 um per section. Just prior to AFM, tissues were quickly 
thawed in 1XPBS at room temperature and then maintained in 1X PBS supplemented with 
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protease inhibitor cocktail (Roche Diagnostics, 11836170001) and propidium iodide (20ug/ml). 
5-6 force maps were taken of at least two tumors from three mice per group. AFM was 
performed as described (Acerbi et al., 2015). All indentations were taken on an MFP-3D-BIO 
AFM (Asylum Research) mounted on an Olympus X711 inverted fluorescent microscope in an 
TMC acoustic noise enclosure. We used silicon nitride cantilever tips with a 5 um borosilicate 
glass sphere affixed to the tip with a spring constant of 0.06 N/m (Novascan, Boone, IA). The 
cantilever was calibrated with thermal oscillation prior to each experiment. Indentations were 
taken at 20 um/second loading rate with a maximum force of 5 nN, and force maps were 
generated using the FMAP function on IGOR software (Asylum Research). The Hertz method 
was used to calculate elasticity and Poisson’s ratio of 0.5 was used to calculate Young’s elastic 
modulus.  
Statistical analysis 
All p-values were calculated using Student’s unpaired, two-tailed T-Tests. p-values are noted in 
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K14 (basal epithelial) <4% ~0%
K8 (luminal 
epithelial) ~0% ~0%
CD31 (endothelial) ~0% ~0%









Figure 2.1: FSP1-Cre targets breast tumor stromal cells. 
(A) Representative immunofluorescence images showing co-staining of cell lineage markers 
with FSP1-Cre; ROSA-LSL-TdTomato. (B) Quantification of co-staining; represented as co-
stained cells/total number of lineage marker positive cells or co-stained cells/total number of 
TdTomato positive cells. (C) Representative images of αSMA-Cre; ROSA-LSL-TdTomato 
tumors co-stained with FAP. Images demonstrate little TdTomato expression overall, intratumor 
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Figure 2.2: FSP1-Cre mice are normal size and FSP1-Cre deletes DDR2 in CAFs. 
(A) Bar graph showing equivalent body weight (g) of WT and FSP1-Cre mice. (B) Total tumor 
genotyping showing DDR2 locus recombination (C) Western blot demonstrating DDR2 



























































































































































































Figure 2.3: Stromal DDR2 is required for breast cancer lung metastasis. 
(A) Primary tumor growth rate in WT; MMTV-PyMT versus FSP1-Cre; DDR2 fl/fl; MMTV-
PyMT mice as represented by time to end stage (single tumor >2cm). n = 10-18 per group. (B) 
Total primary tumor burden in WT; MMTV-PyMT versus FSP1-Cre; DDR2 fl/fl; MMTV-PyMT 
mice. Represented as the total volume of all primary tumors per mouse. n = 10-18 per group. (C) 
Number of lung metastases in WT; PyMT or FSP1-Cre; DDR2 fl/fl; MMTV-PyMT mice, 
represented at average number of lung metastases per whole lung. n = 10-18 per group. ** p = 





































































































































Figure 2.4: DDR2 action in the stroma does not affect fibrosis. 
(A) Representative images of trichrome staining (top) and picosirius red staining (bottom) in 10-
12 week WT; MMTV-PyMT or FSP1-Cre; DDR2 fl/fl; MMTV-PyMT tumors. (B) 
Quantification of area of picosirius red staining per area of tumor. n = 8 per group. (C) 
Hydroxyproline quantification in 10-12 week WT; MMTV-PyMT or FSP1-Cre; DDR2 fl/fl; 


































































































































Figure 2.5: DDR2 affects collagen alignment, fiber width, and fiber length 
(A) Representative second harmonic images (SHG) of 10-12 week WT; MMTV-PyMT or FSP1-
Cre; DDR2 fl/fl; MMTV-PyMT tumors. (B) Quantification of TACS-1 vs TACS 2/3 phenotype 
in (A). n = 6 per group. (C) Quantification of collagen fiber length in WT; MMTV-PyMT or 
FSP1-Cre; DDR2 fl/fl; MMTV-PyMT tumors (same images as in (A)) as calculated using CT-
FIRE software (LOCI, Madison, WI). ** p = 0.003 (D) FIB-SEM reconstruction of collagen 
fibers from WT; MMTV-PyMT or FSP1-Cre; DDR2 fl/fl; MMTV-PyMT. Images are 
pseudocolored to indicate intensity of signal. In each image, the viewer is looking directly at the 
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Figure 2.6: Stromal DDR2 affects mechanical properties of tumors. 
(A) Schematic representation (left) and representative stiffness maps from WT; MMTV-PyMT 
tumor- either tumor core (left) or tumor – stromal boundary (right). (B) Compiled tumor stiffness 
measurements for WT; MMTV-PyMT or FSP1-Cre; DDR2 fl/fl; MMTV-PyMT mice. Data are 
represented as histograms fit with a Gaussian curve. (C) Average stiffness of WT; MMTV-
PyMT or FSP1-Cre; DDR2 fl/fl; MMTV-PyMT tumors. *** p = 0.0008 (D) Stiffness of the 
tumor – stromal boundary of WT; MMTV-PyMT or FSP1-Cre; DDR2 fl/fl; MMTV-PyMT 
tumors. (E) Stiffness of the tumor core of WT; MMTV-PyMT or FSP1-Cre; DDR2 fl/fl; 
MMTV-PyMT tumors. (F) Quantification of (D) and (E). n = 6 tumors per group, data plotted 
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Chapter 3: DDR2 is critical for matrix 
remodeling by cancer associated fibroblasts. 
 
3.1 Introduction 
 Breast tumors are made up of a complex milieu of cells and matrix components, 
including ECM proteins, soluble paracrine factors, and enzymes (Joyce and Pollard, 2009). This 
mixture can promote cancer progression in a number of ways- Non-cancerous cell types, such as 
cancer associated fibroblasts, have been shown to promote tumor aggression and metastasis 
through secretion of paracrine factors and changes in the extracellular matrix (Kalluri, 2016; 
Potenta et al., 2008). Increased stromal collagen deposition, alignment of collagen fibers, and 
fiber thickening have all been associated with local tumor invasion and poor prognosis (Conklin 
et al., 2011; Levental et al., 2009; Provenzano et al., 2006; Provenzano et al., 2008). Tissue 
stiffness, especially at leading edges of invading tumor cells, has been shown to predict 
aggressive breast cancer subtypes (Acerbi et al., 2015; Lopez et al., 2011) and is known to 
reciprocally increase intracellular tension, leading to increased cellular contractility and 
improved invasion (Oudin and Weaver, 2016; Paszek et al., 2005; Provenzano et al., 2009). It is 
not yet fully known which factors or cell types are responsible for altering the breast stroma to 
one which promotes tumor aggression.   
 The Longmore lab has demonstrated that the collagen binding receptor tyrosine kinase 
DDR2 is necessary in both the breast basal epithelial cells and the host for breast cancer lung 
metastasis (Corsa et al., 2016). Further, using the stromal specific FSP1-Cre, we have more 
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precisely demonstrated that DDR2 in stromal cells is required for breast cancer lung metastasis 
(see; chapter 2). In all cases, DDR2 expression had no effect on tumor growth or tumor latency, 
suggesting that the reduction in lung metastases is due to a defect in escape from the primary 
site, survival in the periphery, or re-growth in distant organs. Unpublished work in the lab has 
shown that in a tail vein injection model, there are no differences in lung colonization between 
DDR2 null mice and wild type when injected with wild type tumor cells, suggesting that DDR2 
in the lung is not necessary for extravasation, seeding, and outgrowth of tumor cells. In addition, 
no differences in circulating tumor cells (CTCs) were found in DDR2 null mice or in a transplant 
model, suggesting that there is no defect in intravasation or survival in the bloodstream related to 
DDR2 action (Corsa et al., 2016). In sum, these data suggest that the primary means by which 
breast cancer metastasis is reduced in this model lies in the ability of the tumor to locally invade 
away from the primary site. It was shown that both DDR2 null basal epithelial cells and DDR2 
null CAFs regulate collective invasion of tumor organoids, though whether this effect was 
through paracrine secretion, direct contact between cells types, or due to changes in the 
surrounding ECM was not established (Corsa et al., 2016). 
 Analysis of the tumor stroma in these models have collectively demonstrated a defect in 
collagen architecture related to DDR2 action . DDR2 -/-; MMTV-PyMT (Corsa et al., 2016) and 
FSP1-Cre; DDR2 fl/fl; MMTV-PyMT tumors (see; chapter 2) have a predominantly TACS-1 
collagen phenotype. The collagen fibers near the tumor – stromal boundary are thin and curly 
rather than thick and straightened. Further, FIB-SEM analysis of tumor ECM collagen fibers 
shows reduced thickness of fibers as well as reduced total collagen amount in 10-11 week old 
DDR2 global null; MMTV-PyMT tumors which is in agreement with published data (see; 
chapter 2 and (Corsa et al., 2016)). In DDR2 -/-; MMTV-PyMT mice, but not in MMTV-Cre; 
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DDR2 fl/fl; MMTV-PyMT or K14-Cre; DDR2 fl/fl; MMTV-PyMT mice, reduced overall 
fibrosis was seen in end stage tumors (Corsa et al., 2016). This suggested that DDR2 in the host 
enhanced collagen deposition in breast cancer, however no difference in fibrosis or collagen 
content was seen in FSP1-Cre; DDR2 fl/fl; MMTV-PyMT tumors. Further work is required to 
determine the cause of reduced total fibrosis in the DDR2 global null model.  
 In previously published work from the Longmore lab, we demonstrated that DDR2 is 
necessary in CAFs for the production of an aligned matrix ex vivo, suggesting that the defect in 
collagen alignment in vivo is due to defective CAF function (Corsa et al., 2016). In this study, we 
sought to determine whether DDR2 in CAFs is required matrix remodeling. We show that DDR2 
re-expression can rescue the collagen alignment defect and confirm that DDR2 is not required 
for incorporation of collagen into matrix. We further show that DDR2 action affects cellular 
contractility and the generation of intracellular tension in CAFs.  
 
3.2 Results 
CAF DDR2 is required for collagen alignment but not collagen incorporation into ECM. 
 Extracellular matrix maintenance depends upon a balance of matrix production and 
matrix remodeling, which includes both degradation and fiber rearrangement. In cancer, normal 
homeostasis goes awry and leads to increased collagen deposition and acquisition of an 
aggressive collagen fiber phenotype (Lopez et al., 2011; Provenzano et al., 2006; Provenzano et 
al., 2008). Since we had previously seen a change in breast stromal collagen signature (TACS) in 
stromal knockout FSP1-Cre; DDR2 fl/fl; MMTV-PyMT mice and since fibroblasts are primarily 
responsible for matrix production and remodeling, we wanted to test the effect of DDR2 on 
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breast CAFs (see; chapter 2). Breast CAFs were isolated from 10-12 week old WT; MMTV-
PyMT or FSP1-Cre; DDR2 fl/fl; MMTV-PyMT tumors and immortalized by escape from 
senescence (greater than 20 passages). Resultant cell lines were tested for the presence of typical 
CAF markers, including α-SMA, N-cadherin and FSP1, and the absence of epithelial markers 
such as E-cadherin (Fig 3.1a). Cells were also shown have a fibroblast-like cellular morphology 
by immunofluorescence (Fig 3.1b).  
 To determine whether DDR2 affected CAF matrix assembly, CAFs were plated to 
hyperconfluency and supplemented with ascorbic acid for 7 days. Ascorbic acid was replenished 
every other day. After 7 days, CAFs were extracted from the extracellular matrix by alkaline 
detergent extraction. Resultant cell-free ECMs were stained for collagen 1α1 and imaged by 
confocal microscopy. Results indicate that DDR2 is required for the formation of an aligned 
collagen matrix (Fig. 3.1c) and that this phenotype is specific to DDR2. FSP1-Cre; DDR2 fl/fl 
CAFs rescued with DDR2-myc transduction (Fig. 3.1d) were able to make an aligned matrix 
(Fig. 3.1c, right). Some of these similar data have been previously published in other reports 
from the Longmore lab (Corsa et al., 2016).  
 Because changes in ECM structure can be due to matrix protein production, remodeling, 
or both, we wanted to test whether DDR2 in CAFs had an effect on the amount of collagen 
which was incorporated into ex vivo produced ECMs. In in vivo models, no change in collagen 
content was apparent, though collagen architecture was altered in the presence of stromal DDR2 
(Figs. 2.4, 2.5). To test collagen incorporation into ex vivo ECMs, cell-free ECM was hydrolyzed 
to constituent amino acids and the amount of hydroxyproline was measured by colorimetric 
assay. Results show no difference in hydroxyproline content between WT and FSP1-Cre; DDR2 
fl/fl CAFs (Fig. 3.1e). Taken together, these results suggest that DDR2 action in CAFs is 
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required to remodel matrix to an aligned collagen phenotype but is not required for the 
incorporation of collagen into ECM.  
 
CAF DDR2 affects cellular mechanotransduction/mechanosignaling.  
 It is not entirely known how collagen fibers become aligned in an ECM, however one 
proposed mechanism involves cells pulling on fibers and thereby reorienting them (Sawhney and 
Howard, 2002). Since ECMs from FSP1-Cre; DDR2 fl/fl CAFs were unable to make an aligned 
matrix, we tested whether their cellular contractility was affected. To do so, WT or FSP1-Cre; 
DDR2 fl/fl CAFs were embedded into 1mg/ml collagen gels and allowed to contract that gel 
over three days. At day 3, the collagen gels were imaged and percent gel area remaining was 
quantified. WT CAFs were able to contract a collagen gel to less than 5% of the original gel area, 
while FSP1-Cre; DDR2 fl/fl CAFs were not (Fig. 3.2a). This result was also seen when human 
CAFs (hCAF), WT or shDDR2, were embedded in collagen gels (Fig. 3.2b). shDDR2 
knockdown is shown in Figure 3.2c. These results indicate that DDR2 is required in CAFs for 
robust cellular contractility, a hallmark of activated fibroblasts.  
 Mechanical signals are transmitted to cells through contacts with their extracellular 
microenvironment. These contacts are made up of transmembrane receptors for matrix proteins 
and the coordinated complex of proteins in focal adhesion complexes that link these receptors to 
the actin cytoskeleton (Liu et al., 2015; Wozniak et al., 2004). When extracellular matrix 
stiffness increases, a reciprocal increase in intracellular tension is observed. One indication of 
increased intracellular tension is focal adhesion size; as the cell pulls harder on stiff matrix, focal 
adhesions enlarge to be able to transmit that force (Riveline et al., 2001). We observed focal 
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adhesions in WT and FSP1-Cre; DDR2 fl/fl CAFs by staining for vinculin. Cells were plated on 
collagen 1 or fibronectin coated coverslips and allowed to adhere and spread out overnight. Focal 
adhesions were imaged by confocal microscopy and area of vinculin staining quantified. As can 
be seen in figure 3.2d, the area of vinculin staining in FSP1-Cre; DDR2 fl/fl CAFs is 
significantly smaller (3.2 um2) than that of WT CAFs (4.4 um2), indicating an overall decrease in 
focal adhesion size. Further, this effect was only seen when cells were plated on collagen 1, no 
difference in vinculin staining was seen when plated on fibronectin (Fig. 3.2e, f). Reduced focal 
adhesion size was also found when hCAFs were shDDR2 depleted (Fig. 3.3c). These results 
indicate that DDR2 action in CAFs is required for cellular contractility and suggests that DDR2 
may play a role in focal adhesion assembly or maturation, further suggesting that DDR2 action in 
CAFs is required for mechanotransduction or mechanosignaling.  
 
DDR2 collagen binding but not kinase activity may be required for mechanotransduction 
or mechanosignaling. 
 DDR2 is a unique receptor tyrosine kinase in that it binds fibrillar collagen rather than a 
soluble ligand. It also has extremely long activation kinetics, on the order of hours (Shrivastava 
et al., 1997; Vogel et al., 1997). DDR2 kinase activity can be abrogated by a mutation in the 
kinase domain (K608E) (Zhang et al., 2013) and collagen binding can be disrupted by a mutation 
in the DS domain (W52A) (Carafoli et al., 2009; Ichikawa et al., 2007). The W52A mutant 
retains kinase activity, however it cannot be activated. We confirmed these phenotypes by 
expressing DDR2 WT, K608E, and W52A in HEK 293T cells in the presence or absence of 
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collagen 1 overnight. As can be seen by both phospho-DDR2 and IP-pTyrosine blot, only WT 
DDR2 is phosphorylated in the presence of collagen 1 (Fig. 3.3b).   
To test whether DDR2 kinase activity or DDR2 collagen binding can rescue the focal 
adhesion size defect found in DDR2 shRNA depleted hCAFs, we rescued DDR2 expression with 
YFP-tagged DDR2-WT, DDR2-K608E, or DDR2-W52A by viral transduction. Cells were then 
plated on collagen 1-coated coverslips overnight and stained for vinculin (Fig. 3.3a). Only cells 
expressing similar levels of DDR2-YFP as quantified by fluorescence intensity were included in 
our analysis (Fig. 3.4c). Results indicate that DDR2 collagen binding but not kinase activity is 
required to rescue focal adhesion size. hCAF shDDR2 resWT and hCAF shDDR2 resK608E 
cells had similar focal adhesion size as hCAF shSCR controls, while hCAF shDDR2 resW52A 
results were unchanged from hCAF shDDR2 cells (Fig. 3.3c).  
While focal adhesion size can be indicative of intracellular tension, we also wanted to see 
if there was a difference in mechanosignaling to actomyosin contractility machinery. Cellular 
contractility is dependent on adhering to a substrate and actomyosin machinery; cells cannot 
contract in the presence of myosin inhibitors, for example (Calvo et al., 2013). Cells also cannot 
form mature focal adhesions without the ability to pull on the ECM (Humphrey et al., 2014; 
Zhou et al., 2017). Myosin is activated in a Rho/ROCK dependent manner whereby Rho GTPase 
activates ROCK which in turn activates Myosin Light Chain Kinase (MLCK) and inhibits MLC 
Phosphatase. MLCK phosphorylates Myosin Light Chain (MLC), leading to cell contraction and 
stress fiber formation (Riching and Keely, 2015). To determine whether reduced focal adhesion 
size was indicative of reduced intracellular tension, we stained hCAFs for pMLC levels. Cells 
were imaged by confocal microscopy and the amount of pMLC, corrected for cell size, was 
quantified. Results indicate that focal adhesion size correlates with total cellular pMLC levels. 
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hCAF shDDR2 cells had less total pMLC than controls, and this phenotype was rescued by 
DDR2-WT and DDR2-K608E but not DDR2-W52A (Fig. 3.4a, b). Again, only cells with a 
similar amount of DDR2-YFP expression were considered in the analysis (Fig. 3.4c). These 
results suggest that DDR2 collagen binding but not kinase activity is required for CAF 
mechanotransduction or mechanosignaling.  
 
DDR2 collagen binding but not kinase activity is required for cellular traction force.  
 The ability to generate intracellular tension allows a cell to respond to its extracellular 
microenvironment and generate traction forces upon it. Traction force, or pulling, on fibers can 
be one method by which cells remodel matrix (Sawhney and Howard, 2002). To test whether 
cellular traction force is defective in DDR2 depleted hCAFs, we plated cells on soft (792 Pa) 
collagen 1-coated hydrogels embedded with fluorescent beads and allowed them to adhere and 
spread out overnight (Fig. 3.5a). The next day, initial images of the tense state were acquired, 
cells were then trypsinized to release tension in the gel, and re-imaged. By comparing the 
position of the fluorescent beads before and after trypsinization, bead displacements can be 
measured, and, in combination with known characteristics of the hydrogels, local traction forces 
can be calculated. Results of this experiment indicate that DDR2 is required for the generation of 
traction forces, and that collagen binding but not kinase activity is necessary (Fig. 3.5b). The top 
row shows a heat map of the bead displacement field, the middle row shows the same images 
overlaid with bright field images of the cells, and with forces calculated in the bottom row (Fig. 
3.5b). These data, taken together with focal adhesion size and pMLC level data, suggest that 
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DDR2 collagen binding positively affects the mechanical properties of CAFs and is sufficient to 
promote increased traction forces and intracellular tension.    
 
3.3 Discussion 
 Matrix remodeling is a fundamental process in both normal matrix homeostasis and 
cancer. We have shown in other studies that CAFs isolated from FSP1-Cre; DDR2 fl/fl; MMTV-
PyMT are unable to make an aligned collagen matrix, however the cellular or molecular 
mechanism for how this change occurs was not established (Corsa et al., 2016). In this study, we 
show that DDR2 re-expression in FSP1-Cre; DDR2 fl/fl CAFs can rescue the collagen alignment 
defect found in FSP1-Cre; DDR2 fl/fl CAFs, however, similar to in vivo experiments (chapter 2), 
this defect does not appear to be due to the ability of CAFs to incorporate collagen into the 
matrix (Fig. 3.1). This may be explained by the possibility that collagen alignment is mostly due 
to matrix modeling or re-modeling and not by production of collagen. Further work is needed to 
determine if enhancing a CAF’s ability to remodel, ie- by increasing contractility, for example, 
can rescue the collagen alignment defect in FSP1-Cre; DDR2 fl/fl CAFs.  
 In this study, we have shown that DDR2 action affects the mechanotransducing and 
mechanosignaling properties of CAFs. The ability of a cell to sense, transmit, and respond to 
mechanical information about its extracellular matrix environment is critical for effective cellular 
adaptation and survival (Hytonen and Wehrle-Haller, 2016; Matthews et al., 2006; Provenzano et 
al., 2009; Provenzano and Keely, 2011). In breast cancer, tissues stiffen as cancer progresses and 
this increased stiffness causes a reciprocal increase in intracellular tension and contractility in 
tumor and stromal cells (Lopez et al., 2011). Here we show that DDR2 action promotes marked 
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contraction of collagen gels, growth of focal adhesions in response to mechanical load, and 
increased intracellular tension (Fig. 3.2-4). These data support the idea that DDR2 is a novel 
mechanosensing or mechanotransducing cell surface receptor and critical for matrix remodeling. 
Many groups have shown that cells pull on collagen fibers and that these forces are transmitted 
over long distances (Sawhney and Howard, 2002). It is likely that small traction forces on 
collagen fibers from cells causes alignment of those fibers. Here we show that shDDR2 depleted 
human CAFs have very little ability to generate individual cell traction forces (Fig. 3.5). If a cell 
cannot contract or pull on its surroundings, a cell cannot remodel collagen fibers. 
 Here we demonstrate a novel kinase independent function of DDR2 in CAFs. DDR2 
binds and is activated by fibrillar collagens. Full activation of the receptor takes several hours 
and leads to phosphorylation of several tyrosine resides in the cytoplasmic tail. Both kinase 
activity and the ability to bind collagen are necessary for DDR2 signaling functions (Shrivastava 
et al., 1997; Vogel et al., 1997). Most studies to date have focused on the kinase dependent 
functions of DDR2, though some recent reports and unpublished data from the Longmore lab 
indicate that DDR2 may have kinase-independent functions (Xu et al., 2012). In this study, 
kinase dead DDR2 (K608E) is able to fully rescue growth of focal adhesion, intracellular 
phospho-MLC levels, and traction forces in shDDR2 depleted human CAFs. In sum, these data 
suggest that canonical signaling pathways downstream of DDR2 activation are unlikely to play a 
direct role in matrix remodeling. Collagen binding, however, is required. It is possible that 
DDR2 collagen binding promotes DDR2 clustering, which creates a local increase in the 
concentration of kinase independent signaling partners. It is also possible that DDR2 collagen 
binding allows it to act as a co-receptor for other transmembrane signaling molecules. Further, 
since integrins are the collagen receptors which are typically thought of in cell adhesion, 
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migration, and contraction, it is possible that DDR2 is directly or indirectly affecting integrin 
activity (Xu et al., 2012).  
 In conclusion, the work presented here may explain, in part, how CAFs remodel collagen 
matrix to an aligned phenotype in breast tumor stroma. DDR2 appears to be a novel 
mechanosensing/mechanotransducing transmembrane receptor which influences a cell’s ability 
to contract and generate force, and, thus, move collagen fibers.  
 
3.4 Materials and Methods  
 
Isolation of CAFs 
MMTV-PyMT tumors were dissected, minced, and minced pieces transferred to ∼20 mL of 
digestion media per tumor (DMEM, 1% fbs, 0.2% Collagenase A (Roche), 0.2% trypsin (Gibco 
27250-018), 50 µg/mL gentamycin, 5 µg/mL insulin) and rocked at 37 degrees for 30–45 
minutes. The digested tissue was then washed twice with serum free media and treated with 
DNAse for 5 min at room temperature. Tissue was resuspended in ice-cold serum free media and 
serially centrifuged four times. Single cell fractions were collected and plated for 25–30 minutes 
in DMEM, 10% fbs at 37 degrees Celsius, 5% CO2, 20% O2. CAFs will be adhered to the plate 
while other cells will not. The supernatant and non-adherent cells were removed and CAFs were 
maintained in DMEM, 10% fbs at 37 degrees Celsius, 5% CO2, 20% O2 for 20+ passages, 
splitting 1–2 times per week. The immortalized primary cell lines were then submitted to FACS 




ex vivo ECM synthesis and analysis 
Human CAFs were plated to confluence on 12mm glass coverslips in DMEM supplemented with 
10% FBS and 50 µg/ml ascorbic acid, and media was changed daily for 7 days. Cells were 
extracted on day 7 (25 mmol/L Tris-HCl, pH 7.4; 150 mmol/L sodium chloride; 0.5% Triton X-
100; and 20 mmol/L ammonia hydroxide) for 3–5 minutes. Cellular debris was carefully washed 
away with 1X PBS. Resultant cell free ECMs were fixed in 4% paraformaldehyde for 15 minutes 
at room temperature and then blocked with 5% FBS in 1X PBS. ECMs were then incubated in 
mouse anti-fibronectin antibody (diluted 1:100, BD Biosciences) overnight at 4 degrees, washed 
twice, and then incubated in goat anti-mouse AlexaFluor 488 secondary (diluted 1:500, Life 
Technologies), washed four times, mounted in Vectashield (VWR, 101098-044), and sealed with 
nail polish. Immunofluorescence was analyzed on a confocal microscope (LSM 700; Carl Zeiss, 
Jena, Germany) at room temperature with Zen 2009 software. ImageJ was used to adjust 
brightness and contrast. 
Hydroxyproline quantification 
Cell-free ex vivo ECMs were collected and dried overnight in a lyophilizer and then hydrolyzed 
in 6N HCl (Thermo Fisher Scientific P24308) at 103-106 degrees Celsius for 48 hours. Samples 
were then re-dried in a lyophilzer and resuspended in water. Total protein and hydroxyproline 
were quantified separately. Total protein amount was assayed by adding 100ul of working 
solution (245mg ninhydrin (Sigma 151173), 9ml ethylene glycol, 4.8m 4N sodium acetate, 0.3ml 
SnCl2 (100mg/1mL ethylene glycol)) to 5uL of resuspended hydrolyzed protein, baked at 85 
degrees Celsius for 10 minutes, and then read at 575nm on a plate reader. Standard curve 
generated using Pickering #0125056H. Hydroxyproline was assayed by adding to 50 ul of 
sample, 100 ul of chloramine T at room temperature for 20 min, then adding 100ul Erlich’s 
solution at 65 degrees Celsius for 20 min. The plate was then read at 550nm on a plate reader. 
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Standard hydroxyproline resuspended at 1mg/ml (Sigma H54409). Results are reported as 
fraction hydroxyproline per mg total protein. 
Western blotting 
Cells were lysed in 1X RIPA buffer supplemented with 1mM PMSF, 1mM sodium vanadate, 
1mM sodium fluoride, and 10 ug/ml each aprotinin and leupeptin. Lysates were sonicated twice 
for 30 seconds and centrifuged at 14,000 RPM, 10 min. Cleared lysates were separated by SDS-
PAGE, transferred onto PVDF membrane, and blocked for 1 hour at room temperature in 5% 
non-fat dry milk, 1X TBS-0.5% Tween. Membranes were incubated in primary antibody 
overnight at 4 degrees with gentle agitation, washed twice with TBS-0.5% Tween, and incubated 
with anti-mouse or anti-rabbit HRP secondary antibody for one hour at room temperature. 
Membranes were then washed four times with TBS-0.5% Tween and developed with ECL 
(Pierce, 32106). 
Gel contraction 
2 x 105 CAFs were embedded in 100 ul of 1mg/ml collagen 1 gel (Rat tail collagen, Corning 
CB354249) which was then spread with a pipet tip into the well of glass bottom 12mm Mattek 
dishes. The gel was allowed to solidify at 37 degrees Celsius for 20 min after which 2 mL of 
DMEM + 10% fbs was added and gels were gently detached with a pipet tip. Gels were imaged 
after 3 days, and percent contraction was calculated relative to initial gel area by tracing in 
ImageJ.  
Immunofluorescence on cells 
For collagen or fibronectin coating, 50 ug/mL collagen or fibronectin in water was spread on 
12mm glass coverslips (no. 1.5, high precision) and allowed to dry at room temperature 
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overnight. The next day, the coverslips were blocked with 1% BSA in PBS for 1 hour at room 
temperature and sterilized under UV for 20 min. Cells were plated sparesly (1 x 104 per 
coverslip) and allowed to adhere and spread for indicated times. Cells were then fixed in 4% 
paraformaldehyde for 15 minutes at room temperature. Cells were permeabilized in 0.1% Triton 
X-100 in PBS for 5 minutes at room temperature, washed with PBS, and blocked with 5% 
normal goat serum in PBS. Primary antibodies were added and incubated at 4 degrees Celsius 
overnight. Coverslips were washed and secondary fluorescent antibody added for 1 hour at room 
temperature. Coverslips were washed again and mounted in Prolong Diamond mounting 
medium. After curing for 24 hours, cells were imaged by confocal microscopy on NIS-Elements 
software (Nikon A1Rsi, inverted). Z-stacks were taken with a step size of 0.2 um with a 40X 
objective. Z-stacks were flattened by maximum intensity projection, and focal adhesions were 
quantified in ImageJ by subtracting the background, thresholding to the same level for all 
samples, and running particle analysis. p-MLC images were taken in the same manner, but levels 
were quantified by tracing cell outlines and measure integrated density, corrected for background 
and cell area.  
Traction force 
Glass coverslips were activated with 3-APTMS for 5 min and fixed in 0.5% glutaraldehyde for 
30 minutes at room temperature. Hydrophobic coverslips were made by treatment with 
Sigmacote. Soft (792 Pa) polyacrylamide hydrogels were made by polymerizing (final 
concentrations of 5% acrylamide and 0.1% bis-acrylamide with 0.5% dark red fluorescent beads, 
0.2 um (Thermo Fisher Scientific F8807)) gel in a sandwich between the functionalized and 
hydrophobic coverslips. Gels were allowed to polymerize for 30 minutes at room temperature, 
the sandwich separated and washed. The surface of the gel was functionalized with 0.5mg/mL 
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sulfo-SANPAH in 50mM HEPES, pH 8.2 under UV light for 10 min. Gels were extensively 
washed and then incubated with 50 ug/mL collagen 1 in 50 mM HEPES, pH 8.2 overnight at 4 
degrees Celsius. The next day, gels were washed and equilibrated in DMEM. Cells were plated 
sparsely and allowed to adhere and spread overnight. During microscopy, cells were kept at 37 
degrees and under 5% CO2 in an incubated plate holder. Images were taken before and after 
trypsinization, and bead displacements calculated with a Matlab program.  
Statistical Analysis 
All p-values were calculated using Student’s unpaired, two-tailed T-Tests. p-values are noted in 























































































































Figure 3.1: CAF DDR2 is required for collagen alignment but not collagen incorporation 
into ECM.  
(A) Western blots of WT and FSP1-Cre; DDR2 fl/fl CAFs showing expression of mesenchymal 
and CAF markers. (B) Representative images of WT and FSP1-Cre; DDR2 fl/fl CAFs stained 
with Phalloidin-568 which has been pseudocolored green. (C) ex vivo produced ECMs from WT, 
FSP1-Cre; DDR2 fl/fl, or FSP1-Cre; DDR2 fl/fl resDDR2-WT CAFs. Cells are extracted and 
resultant cell-free ECMs stained for collagen 1. (D) Western blot showing relative Ddr2 
expression in WT, FSP1-Cre; DDR2 fl/fl, and FSP1-Cre; DDR2 fl/f; resDDR2-WT CAFs. (E) 
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Figure 3.2: CAF DDR2 affects cellular mechanotransduction/mechanosignaling.  
(A) Collagen gel contraction of WT and FSP1-Cre; DDR2 fl/fl CAFs. Data are presented as 
percent gel remaining. n = 6 per group. * p = 0.28 (B) Collagen gel contraction of human CAF 
shSCR and shDDR2. Data are presented as percent gel remaining. n = 3 per group. ** p = 0.006 
(C) Western blot showing relative knockdown of DDR2 in hCAF shSCR and shDDR2 cells. (D) 
Representative confocal image of focal adhesions in WT and FSP1-Cre; DDR2 fl/fl CAFs. (E) 
Quantification of focal adhesion size on collagen coated coverslips. *** p < 0.0001 (F) 



































































































































Figure 3.3: DDR2 collagen binding but not kinase activity is required for 
mechanotransduction or mechanosignaling. 
(A) Representative confocal images of focal adhesions in hCAF shSCR and hCAF shDDR2 
cells. (B) IP-pTyr and Western blot showing DDR2 phosphorylation status after collagen 
stimulation for YFP-tagged DDR2 WT, DDR2 K608E, and DDR2 W52A rescue constructs. (C) 
Quantification of focal adhesion size on collagen coated coverslips for hCAF shSCR, hCAF 






































































































































































Figure 3.4: DDR2 collagen binding but not kinase activity is required for increased 
intracellular tension.  
(A) Representative confocal images of hCAF shSCR or hCAF shDDR2 cells stained for p-MLC. 
(B) Quantification of p-MLC levels in hCAF shSCR, hCAF shDDR2 or shDDR2 plus DDR2-
WT, DDR2-K608E, or DDR2-W52A. ** p <0.01 for each. (C) Quantification of DDR2-YFP 
























































Figure 3.5: hCAF traction forces require collagen binding but not kinase activity of DDR2. 
(A) Schematic diagram of traction force protocol. (B) Top row- heat map of bead displacement 
field; middle row- heat map overlaid with bright field image of cells; bottom row- field of 
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Chapter 4: DDR2 action promotes 
recruitment of Talin1 and integrin β1 
activation. 
4.1 Introduction 
 Transmitting mechanical information from the extracellular environment to intracellular 
signaling is essential for cell survival, migration, and differentiation (Hytonen and Wehrle-
Haller, 2016). Critical to these events are cell adhesion receptors such as integrins and 
intracellular structural proteins and signaling partners (Humphrey et al., 2014). Fibroblasts, in 
particular, are especially tuned to respond to changes in extracellular signals like tension and can 
remodel matrix by pulling on tissues, such as in wound healing or cancer (Kalluri, 2016). 
Changes in extracellular matrix architecture through remodeling can cause increased stiffness of 
tissues (Schedin and Keely, 2011), a phenomenon that has been shown to enhance cellular 
invasion through a process known as durotaxis (Lo et al., 2000; Pelham and Wang, 1997) and 
correlates with breast tumor progression and aggressive breast cancer subtypes (Acerbi et al., 
2015; Butcher et al., 2009). Increased substrate stiffness causes a reciprocal increase in 
intracellular tension in cells. This tension is transmitted from the actin cytoskeleton to adhesions 
through actomyosin contractility and focal adhesion complexes (Liu et al., 2015). Focal 
adhesions grow larger and stronger under mechanical load, thereby enabling a cell to pull harder 
on its substrate (Riveline et al., 2001).  
Collagen receptor crosstalk is likely to play a role in regulating cell behavior in response 
to extracellular signals, but little work has gone into understanding the crosstalk between the 
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discoidin domain receptors and integrins. Discoidin domain receptors and integrins bind distinct 
collagen motifs (Leitinger et al., 2004; Xu et al., 2012), and it is known that DDR1 and DDR2 
activation can occur independent of integrins (Vogel et al., 2000; Zhang et al., 2013). The 
reverse has not been fully explored, though it has been shown that DDR2 binding to DDR2 
specific ligand positively influences cell adhesion by enhancing the activity of integrins 
alphα1β1 and α2β1. This increase in integrin activity was not due to a change in the amount of 
integrin β1 expressed on the cell surface, indicating that DDR2 activity is sufficient to induce a 
conformational change in integrins (Xu et al., 2012). The mechanism for how DDR2 activity 
promotes integrin activation was not defined.  
Integrins can be activated bidirectionally, either through contacts with ECM ligands 
(outside-in) or through intracellular signaling events that ultimately promote talin1 recruitment to 
integrin β1 cytoplasmic tails and subsequent integrin conformational change and activation 
(inside-out) (Kim et al., 2011). This increase in integrin affinity for ligand is complemented by 
increases in avidity. As integrins are activated at adhesions, more are recruited and activated via 
talin1 and kindlin proteins, serving to strengthen and grow the focal adhesion complex (Kahner 
et al., 2012). The pathways upstream of talin1 recruitment have not been fully elucidated though 
much work has been accomplished. Understanding these critical signaling mechanisms for 
mechanotransmission will be important in determining how tumor stroma is remodeled and how 
cancer cells metastasize.  
In this study, we sought to understand the mechanism by which DDR2 promoted larger 
focal adhesions, increased intracellular tension, and greater cellular contractility in breast CAFs 
(see; chapter 3). We show that differences in focal adhesion size exist at early timepoints after 
plating, suggesting a defect in mechanotransduction or mechanosignaling in the absence of 
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DDR2.  We show that integrin β1 activation is reduced without affecting the amount of total 
integrin β1 in cell protrusions and, further, show that DDR2 is required for talin1 recruitment and 
integrin β1 activation. This effect appears to be downstream of increases in Rap1-GTP levels in 




DDR2 action affects early mechanotransmission. 
 As cells spread out and migrate, they form small nascent focal adhesions at the leading 
edges of lamellipodia. Cell surface adhesion molecules, ie- integrins, make contact with substrate 
and are activated either by inside out or outside in signaling (Riveline et al., 2001). These 
signaling events occur within seconds to minutes, and, since earlier studies were done on cells 
plated overnight, we wanted to determine whether DDR2 in CAFs affected early 
mechanotransmission events as well. WT or shDDR2 depleted human CAFs were plated on 
collagen coated coverslips for 30 or 60 min. Cells were then fixed, stained for vinculin, and 
imaged by confocal microscopy. Results indicate that DDR2 is required at early timepoints to 
increase focal adhesion size (Fig. 4.1a). DDR2 depleted CAFs have both a delay in increasing 
focal adhesion size and a lower maximum size, as evidenced by data in Figure 4.1a and 
presented in chapter 3. The focal adhesions of DDR2 depleted cells do not increase in size under 
mechanical load in the same manner as WT DDR2 CAFs. These results indicate that DDR2 is 





DDR2 does not co-localize with or affect the expression of integrin β1 in cell protrusions. 
 Cellular force generation and mechanotransduction on collagen coated coverslips is 
largely dependent on the collagen binding integrins (Xu et al., 2012). There are four collagen 
binding integrins in mammals, all of which have the β1 subunit in common. Further, focal 
adhesion formation and maturation depend on integrin β1 expression and activity. DDR2 has not 
been shown to be a strong adhesive molecule, though cells will adhere but not spread on DDR2 
specific peptide (Xu et al., 2012). Because we observed a defect in focal adhesion size on 
collagen and because DDR2 has been shown by other groups to promote integrin β1 activation, 
we wanted to test whether integrin β1 levels were affected in shDDR2 depleted CAFs.  
 To this end, we sparsely plated shSCR, shDDR2 CAFs on collagen coated coverslips for 
15 min. Cells were then fixed and stained for total integrin β1 and imaged by n-SIM super-
resolution microscopy. We chose super-resolution microscopy in order to get a more detailed, 
higher resolution image of focal adhesion proteins. Quantification of total fluorescence of 
integrin β1 was restricted to regions of interest in cell protrusions and normalized to area. 
Importantly, results indicate that there is no difference in the amount of integrin β1 in cell 
protrusions (Fig. 4.2b), a result that is in agreement with published reports (Xu et al., 2012).  
 Because integrin β1 activity is influenced by its binding partners, we wanted to determine 
if DDR2 was interacting with integrin β1. In a similar manner to above, we plated hCAF 
shDDR2 cells expressing rescue DDR2 WT-YFP cDNA on collagen coated plates for 15 min. 
Cells were then fixed, stained for integrin β1 and talin1, and imaged by n-SIM super-resolution 
microscopy. Co-localization was determined using overlaid images and Pearson’s coefficient 
calculation; the well-established talin1 – integrin β1 interaction was used as a positive control. 
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As can be seen in Figure 4.2a, talin1 and integrin β1 co-localize in cell protrusions (Pearson’ 
coefficient = 0.37) while DDR2-YFP and integrin β1 do not (Pearson’s coefficient = 0.19). 
Importantly, DDR2-YFP also does not co-localize with talin1 (Pearson’s coefficient = 0.17). 
These data indicate that differences in transmission of mechanical signals to focal adhesions in 
CAFs is not due to dysregulation of integrin β1 expression or protrusion localization.  
  
DDR2 action promotes integrin β1 activation and talin1 recruitment. 
 Integrins are activated in a series of conformational changes in both the extracellular and 
transmembrane domains from a bent, closed, inactive, low affinity state to an extended but 
closed inactive state to an extended, open, active, and high affinity state (Kim et al., 2011). These 
conformation changes are generally achieved through application of force at the distal or 
proximal ends of the protein. Talin1 binding to integrin β1 cytoplasmic tails activates and links 
integrin β1 to the actin cytoskeleton, creating a mechanical bridge whereby actomyosin 
contractility can act upon integrin adhesions (Klapholz and Brown, 2017).  
 To determine if DDR2 affects integrin β1 activation or talin1 recruitment, we plated 
hCAF shSCR or shDDR2 on collagen coated coverslips for 15min. The cells were then fixed and 
stained with antibody against the extended conformation of integrin β1 (9EG7 clone), indicating 
partial or full activation, and talin1. Samples were imaged by n-SIM super-resolution microscopy 
and amount of activated integrin β1 or talin1 quantified. Fluorescence intensity was measured in 
equivalent cell protrusions and normalized to area. Results indicate that DDR2 action is required 
in CAFs for the activation of integrin β1 (Fig. 4.3a, top, quantified in Fig. 4.3b). Remarkably, 
talin1 recruitment to cell protrusions was dramatically inhibited in DDR2 depleted CAFs (Fig. 
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4.3a, bottom, quantified in Fig. 4.3c). Extracellular signal in the talin1 channel is 
autofluorescence from local accumulations in the collagen coating.  
 Since talin1 binding to integrin β1 cytoplasmic tails is a key final step in the full 
activation of integrins, we also assessed whether there was a difference in the co-localization of 
talin1 and activated integrin β1 by super-resolution imaging. As can be seen in Figure 4.4, talin1 
association with active integrin β1 was dramatically reduced in the absence of DDR2 (quantified 
in Fig. 4.4b). To confirm this phenotype, we plated hCAF shSCR or hCAF shDDR2 cells on 
collagen coated plates, lysed the cells, immunoprecipitated talin1, and blotted for integrin β1. 
Results demonstrate that upon collagen stimulation, a sharp rise in talin1:integrin β1 association 
is found in hCAF shSCR but not in hCAF shDDR2 cells (Fig. 4.4c). This is in spite of the fact 
that talin1 IP was equivalent between groups, as was total talin1 and integrin β1 expression. 
These data indicate that while DDR2 action has no effect on talin1 or integrin β1 protein levels, 
it has a dramatic effect on the ability of talin1 to interact with integrin β1. In sum, this result 
identifies a novel pathway by which DDR2, likely in a kinase independent manner, stimulates 
integrin β1 activity by leading to the recruitment of talin1 to adhesions.  
  
DDR2 action increases Rap1-GTP in CAFs. 
  Talin1 is recruited to the membrane and therefore to integrin β1 cytoplasmic tails by 
association with RIAM. RIAM is activated by bound Rap1-GTP, which is upregulated in 
response to many factors, including local PIP2 and Gα13 levels(Lee et al., 2009; Yang et al., 
2014). Because we saw difference in talin1 recruitment and subsequent loss of integrin β1 
activation in shDDR2 depleted CAFs, we asked whether there was a change in Rap1-GTP levels. 
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Cells were serum starved and plated on collagen coated plates for 15min. Cells were lysed and 
Rap1-GTP immunoprecipitated with Ral-GDS-RBD agarose beads (EMD Millipore). 
Immunoprecipitates were separated by SDS-PAGE, transferred to PVDF, and blotted for Rap1. 
Results indicate that Rap1-GTP levels increase 1.5 fold in WT CAFs when stimulated by 
collagen for 15min, but not in shDDR2 depleted CAFs (Fig. 4.6a). Calculations are normalized 
to both β-tubulin and total Rap1 amounts in each sample. These results indicate that DDR2 
action facilitates Rap1-GTP activity in CAFs and suggests a mechanism by which DDR2 action 
promotes talin1 recruitment through increased Rap1-GTP activity.  
 
4.3 Discussion 
 We have shown that DDR2 action in CAFs promotes the activation of integrin β1 without 
affecting the total amount of integrin β1 localized to cell protrusions or in total cell lysate. We 
have further demonstrated that DDR2 facilitates talin1 recruitment and binding to integrin β1 
cytoplasmic tails, likely downstream of increased Rap1-GTP levels. Importantly, DDR2 does not 
interact with integrin β1 or talin1, suggesting that regulation of this interaction is downstream of 
a signaling event rather than mislocalization or other sequestration problem. Because we 
performed these experiments at time points much shorter than DDR2 activation times, it is likely 
that DDR2 activates Rap1-GTP in a kinase independent manner, though we do not yet know 
with certainty. Future studies will utilize DDR2 mutants to parse out the relative contribution of 
collagen binding and kinase activity in this setting. It is also possible that DDR2 clustering is 
required for signal propagation. Other groups have shown that DDR1 mediates collagen 
contraction in a manner that is dependent on clustering and interaction with non-muscle myosin 
IIA (NMAII), however the authors state that DDR1 kinase activity is required for their 
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phenotype (Coelho et al., 2017). It is possible that DDR2 acts in a similar, if kinase independent, 
manner, however we do not yet know if DDR2 interacts with NMAII.  
 Integrin activation is bidirectional, and we have identified a novel mechanism by which 
DDR2 action regulates integrin β1 in an inside – out manner. This result is important because it 
suggests that the phenotypes we see in vivo may be due to reduced integrin β1 activity. Integrin 
activity in cancers have been associated with cell survival, proliferation, and invasion (Keely et 
al., 1998; Levental et al., 2009). Targeting integrin activity as a therapy is not feasible, but if 
there were a way to target integrins indirectly, ie- through inhibition of DDR2, we would expect 
to see not only increased specificity, but decreased toxicity.  Further, Rap1-GTP acts on RIAM 
which recruits and activates talin1 (Lee et al., 2009; Yang et al., 2014). We do not yet know what 
the effect is of DDR2 on RIAM activity, nor do we know the pathway between DDR2 and Rap1-
GTP activity. Future work could focus on identifying more pieces of this pathway. Initial ideas 
would be to test whether DDR2 to Rap1-GTP is a new, independent pathway or if it feeds into 
already described pathways including PIP2, PKC, and Gα13 (Martel et al., 2001; Schiemer et al., 
2016).  
 In summary, we have identified DDR2 as a novel mechanotranducing/mechanosignaling 
collagen binding RTK. While more work remains to tease out the full mechanism, it is clear that 
DDR2 action promotes talin1 recruitment and subsequent integrin β1 activation in CAFs, likely 





4.4 Materials and Methods  
 
Immunofluorescence and microscopy 
For collagen coating, 50 ug/mL collagen in water was spread on 12mm glass coverslips (no. 1.5, 
high precision) and allowed to dry at room temperature overnight. The next day, the coverslips 
were blocked with 1% BSA in PBS for 1 hour at room temperature and sterilized under UV for 
20 min. Cells were serum starved and removed from tissue culture plates non-enzymatically. 
They were then plated sparesly (1 x 104 per coverslip) and allowed to adhere and spread for 
indicated times. Cells were then fixed in 4% paraformaldehyde for 15 minutes at room 
temperature. Cells were permeabilized in 0.1% Triton X-100 in PBS for 5 minutes at room 
temperature, washed with PBS, and blocked with 5% normal goat serum in PBS. Primary 
antibodies were added and incubated at 4 degrees Celsius overnight. Coverslips were washed and 
secondary fluorescent antibody added for 1 hour at room temperature. Coverslips were washed 
again and mounted in Prolong Diamond mounting medium. Coverslips were allowed to cure for 
24 hours. For focal adhesion quantification, cells were imaged by confocal microscopy on NIS-
Elements software (Nikon A1Rsi, inverted). Z-stacks were taken with a step size of 0.2 um with 
a 40X objective. Z-stacks were flattened by maximum intensity projection, and focal adhesions 
were quantified in ImageJ by subtracting the background, thresholding to the same level for all 
samples, and running particle analysis. For n-SIM super-resolution microscopy, images were 
taken with NIS-Elements software on a Nikon Ti-E microscope with a high NA 100X objective. 
Fluorescence was captured with an Andor Zyla 4.2 Megapixel sCMOS camera. Z-stacks were 
taken for all images with a step size of 0.15um. n-SIM images were reconstructed in NIS-




Tissue culture dishes were coated with 50 ug/mL collagen in water and allowed to dry overnight 
at room temperature. The next day, dishes were blocked with 1% BSA for 1 hour at room 
temperature and then sterilized under UV light for 20min. Cells were serum starved overnight 
and then removed from plates non-enzymatically. Cells were allowed to adhere for 1 hour and 
then lysed in 20mM Tris, pH 7.5, 1% Triton X-100, 0.1% SDS, 150 mM CaCl2 supplemented 
with 1mM PMSF, 1mM sodium vanadate, 1mM sodium fluoride, and 10 ug/ml each aprotinin 
and leupeptin. Equal amounts of protein were pre-cleared with Protein G sepharose beads and 
then incubated with talin1 antibody overnight with gentle agitation. Protein G sepharose beads 
were added for 1 hour at 4 degrees, then beads were washed four times with CoIP buffer, 
resuspened in 2X Laemmli sample buffer, boiled, and separated by SDS-PAGE.  
Rap1-GTP assay 
For Rap1-GTP immunoprecipitation, we followed the manufacturer’s instructions (EMD 
Millipore 17-321). Briefly, cells were serum starved overnight and then plated on collagen 
coated tissue culture dishes for 15 min. They were lysed in the supplied lysis buffer supplement 
with 1mM PMSF, 1mM sodium vanadate, 1mM sodium fluoride, and 10 ug/ml each aprotinin 
and leupeptin. Samples were sheared with passages through 27G needle, spun, and supernatents 
incubated with Ral-GDS-RBD agarose beads at 4 degrees for 45 minutes. Beads were washed 
and resuspended in 2X Laemmli buffer, boiled, and separated by SDS-PAGE. 
Statistical Analysis 
All p-values were calculated using Student’s unpaired, two-tailed T-Tests. p-values are noted in 







































































Figure 4.1: DDR2 affects mechanotransduction/mechanosignaling at early timepoints. 
(A) Quantification of focal adhesion size at 30 and 60 min for hCAF shSCR and hCAF shDDR2. 

































































































Figure 4.2: DDR2 does not interact with or affect expression of integrin β1.  
(A) Top; Representative super-resolution images of DDR2-YFP, integrin β1, and talin1. Scale 
bar = 5 um. Middle; Zoomed in view of white box in top row. Bottom; Gray scale super-
resolution image of individual protein expression. Co-localization quantified by Pearson’s 
coefficient. (B) Quantification of integrin β1 fluorescence in cell protrusions of hCAF shSCR 
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Figure 4.3: DDR2 promotes integrin β1 activation and talin1 recruitment. 
(A) Representative super-resolution images of hCAF shSCR or hCAF shDDR2 showing integrin 
β1 (9EG7) (top) or talin1 expression (bottom) when plated for 15min on collagen coated 
coverslips. Cell boundary outlined in white dotted line. (B) Quantification of integrin β1 (9EG7) 
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Figure 4.4: DDR2 affects talin1 interaction with integrin β1. 
(A) Representative super-resolution images of hCAF shSCR and shDDR2 showing integrin β1 
(9EG7) and talin1 co-localization. Inset- close up of boxed region. (B) Quantification of co-
localization by Pearson’s coefficient. *** p = 0.0004. (C) Coimmunoprecipitation of talin1 and 
integrin β1 and input of hCAF shSCR and shDDR2 cells plated on collagen coated plates or 
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Figure 4.5: DDR2 action increases Rap1-GTP levels in response to collagen. 
(A) Representative Western blots showing Rap1-GTP immunoprecipitation and input controls 
for hCAF shSCR and shDDR2 plated on collagen or control for 15 min. Quantified by 
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Table 1: Primer sequences for DDR2 mouse genotyping. 
Name Sequence (5’ – 3’) 
FRT 5’ Fwd CTGTGTCTCTGGCTCAAAGTGTC 
Targeted exon Rv CCTTCCCAAGGCAGACCATTC 
PyMT Fwd GGAAGCAAGTACTTCACAAGGG 
PyMT Rv GGAAAGTCACTAGGAGCAGGG 
Cre Fwd GCATTACCGGTCGATGCAACGAGTGATGAG 
Cre Rv GAGTGAACGAACCTGGTCGAAATCAGTGCG 
ROSA-LSL-TdTomato Fwd GAGGGCCGCCACCACCTGTTCCTGTACGG 
ROSA-LSL-TdTomato Rv ATGATACAAAGGCATTAAAGCAGCGTATCC 
ROSA-WT Fwd GGGGAGTGTTGCAATACCTTTCTGGGAGTTC 




















Table 2: Antibodies used for Western blot, IF, and IP 
Antibody Source Application Concentration 
Α-SMA (1A4) Sigma A2547 WB 1:10,000 
β-actin Sigma A5441 WB 1:10,000 
β-tubulin Sigma T4026 WB 1:2000 
CD31 Abcam ab28364 IF 1:100 
CD45 BD Biosciences 550539 IF 1:100 
Collagen 1a1 EMD Millipore AB765P IF 1:200 
DDR2 CST 12133 WB 1:1000 
FAP EMD Millipore ABT11 IF 1:100 
Integrin β1 BD Biosciences 552828 IF 1:50 
Integrin β1 CST 4706 WB 1:500 
Integrin β1 (9EG7) BD Biosciences 553715 IF 1:50 
K14 Covance PRB-155P IF 1:100 
K8 DSHB TROMA-1 IF 1:100 
p-MLC (Ser19) CST 3671 IF 1:50 
PDGFRα-FITC eBioscience 11-1401-80 FACS 1:50 
Rap1 EMD Millipore 07-916 WB 1:500 
Talin1 (8D4) Sigma T3287 IF, WB 1:250, 1:2000 













Chapter 5: Conclusions and Future 
Directions 
 
 In summary, we have identified a novel mechanotransducing/mechanosensing pathway 
whereby DDR2 action activates integrin β1 downstream of Rap1-GTP driven recruitment of 
talin1 to adhesions. This promotion of integrin β1 activity is correlated to increased cellular 
contractility and traction force generation in cancer associated fibroblasts (CAFs), which may 
explain, in part, how collagen is remodeled in tumor stroma to generate aligned fibers and an 
increasing stiffness gradient which promotes local invasion and metastasis.  
Stromal roles of DDR2 in the primary tumor site 
 Initial insight into the role of DDR2 in the breast tumor stroma came from previous 
studies in the lab that demonstrated an alteration in the collagen fiber architecture in DDR2 
global null mice. Wild type mice had a predominantly TACS-2/3, or aggressive, phenotype while 
DDR2 global null mice had a predominantly TACS-1, or more benign, phenotype (Corsa et al., 
2016). That study went on to show, in a reciprocal transplant, that DDR2 in the host was required 
for metastasis even when transplanted with wild type tumor. That experiment was not selective 
for any particular part of the host, but, in combination with the data about stromal architecture 
alterations, we hypothesized that the most likely cell type that was contributing was cancer 
associated fibroblasts (CAFs). In this study, we used the stromal specific FSP1-Cre to selectively 
target CAFs as best we could and demonstrated that stromal DDR2 is required for lung 
metastasis. We also show that DDR2 action in the stroma promotes matrix remodeling and the 
generation of a stiffness gradient. However, because FSP1-Cre also targets a population of 
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hematopoietic cells, most likely macrophages, we cannot conclusively state that the results are 
due only to DDR2 action in CAFs. Future work will require a co-transplant experiment in which 
DDR2 +/- CAFs are transplanted with syngeneic wild type or DDR2 null tumor cells into wild 
type or DDR2 null hosts. Expected results would be that no matter the combination, DDR2 null 
CAFs would reduce metastasis while DDR2 wildtype CAFs may actually increase metastasis of 
otherwise previously non-metastatic states, ie- DDR2 null tumor cells in a global null or wild 
type host. This change in metastasis would be correlated to changes in the tumor associated 
matrix, including increased collagen fiber alignment and stiffness.  
 In this study, we propose that DDR2 is a novel mechanosensor or mechanotransducer in 
CAFs and that this activity leads to matrix remodeling downstream of increased integrin β1 
activity and intracellular traction force generation. One way CAFs can alter matrix is by pulling 
on fibers, and it has been shown that even small pulling forces can alter collagen alignment at 
great distances (Sawhney and Howard, 2002). At this time, we cannot directly link cell 
contractility and focal adhesion size to in vivo collagen fiber alterations, however future studies 
may be conducted in which contractility is increased in DDR2 null CAFs. For example, we see 
changes in Rap1-GTP levels that are correlated with talin1 recruitment to adhesions and integrin 
β1 activation. Exogenous expression of constitutively active Rap1 (Katagiri et al., 2000) may 
bypass the requirement for DDR2 and rescue the phenotype. Co-transplant of these CAFs and 
controls with wild type tumor cells would allow analysis of stromal changes. Further, it would be 
interesting to see if we could observe remodeling of existing matrix in vitro. However, an 
experiment like that would require development of a system where one could track which fibers 
are old fibers which have been remodeled and which fibers are newly produced, ie- by 
immunofluorescent labeling or similar. It is likely that both processes will happen in the same 
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location, and teasing them apart will be important. In addition to cell contractility and pulling on 
fibers, matrix remodeling enzymes also likely play a role (Page-McCaw et al., 2007). DDR2 has 
been shown in other studies to control expression of MT1-MMP (MMP14) (Majkowska et al., 
2017; Zhang et al., 2013). MT1-MMP is a transmembrane protease which activates the pro-
enzyme MMP2 (Cathcart et al., 2015). The contribution of MMP expression or activity in 
stromal remodeling has not been tested for DDR2 in CAFs. It will be important to establish 
whether DDR2 in CAFs is required for matrix degradation as well. 
 In previous studies of DDR2 global null mice, a decrease in total fibrosis was observed in 
end stage tumors (Corsa et al., 2016). In this study, despite targeting CAFs, we did not see a 
difference in fibrosis or total collagen content (Fig. 2.4a, b and Fig. 3.1c). One explanation for 
this is that CAFs may be induced to increase synthesis of ECM proteins by paracrine factors 
from tumor or immune cells and that this induction is dependent upon DDR2 expression in those 
cells. In the case of FSP1-Cre, tumor cells and most immune cells are wild type and, therefore, 
have normal (if aberrant) DDR2 expression. Analysis of changes in cytokines and paracrine 
factors from tumor cells and/or immune cells could lend insight into this hypothesis. In this 
context, it would suggest that DDR2 on CAFs is not necessary for fibrosis in breast cancer.  
 In addition to cells and matrix proteins, the tumor microenvironment is under the 
influence of a number of pro-inflammatory, pro-migratory, and pro-survival paracrine factors. 
Fibroblasts can be activated to CAFs under the influence of TGF-β and PDGF, among others, 
from tumor and immune cells (Elenbaas and Weinberg, 2001). CAFs secrete factors such as 
VEGF, IL-6, and EGF to stimulate angiogenesis and inflammation (Kalluri, 2016). Immune cells 
can secrete pro-fibrotic TGF-β and MMPs which contribute to the desmoplastic reaction 
(Elkington et al., 2009). In addition, the secretory profile of CAFs is generally 
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immunosuppressive, which protects tumor cells from immune surveillance and destruction 
(Kalluri, 2016). The effect of DDR2 in this context, in any cell type, has not been examined, 
though some evidence exists that paracrine signaling may be affected. In a mixing experiment, 
DDR2 wild type and null CAFs were co-plated with DDR2 wild type and null tumor organoids. 
The results indicated that DDR2 was required in both cell types, independently for 3D organoid 
invasion (Corsa et al., 2016). The experiment did not test whether this effect was due to a 
paracrine factor, direct contact between cell types, or downstream of matrix remodeling. It would 
be interesting in future work to gain an understanding of how DDR2 action may impact 
angiogenesis and immune infiltration in a paracrine manner from tumor cells, CAFs, or immune 
cells.   
 An emerging line of thought in metastasis research involves the idea that stromal cells 
travel with metastasizing tumor and that this co-travel increases the odds that a disseminated 
tumor cell or group of cells will metastasize (Duda et al., 2010). In the primary site CAFs have 
been shown to lead tumor cells away from the tumor core (Gaggioli et al., 2007). A role for 
DDR2 in stromal traveling with tumor cells has not been explored, though there is evidence in 
our lab and others that DDR2 regulates tumor cell and fibroblast invasion (Corsa et al., 2016; 
Marquez and Olaso, 2014; Olaso et al., 2002; Olaso et al., 2011b; Zhang et al., 2013). 
  
DDR2 regulation of integrins 
 We have shown that DDR2 regulates integrin β1 activity on collagen through inside-out 
signaling at timepoints shorter than the time it takes for full DDR2 activation. We see differences 
in integrin β1 activation levels at 15 min, whereas full DDR2 activation takes several hours. This 
suggests that DDR2 collagen binding is the stimulus for signaling which leads to integrin β1 
137 
 
activation, though we cannot say for certain. Further tests using the DDR2 K608E and DDR2 
W52A mutants will shed more light and allow us to confirm that DDR2 kinase activity is not 
required. Previous studies on focal adhesion size, traction force generation, and intracellular 
tension using pMLC as a readout indicate that kinase activity will not be required (chapter 3). 
Further, we plan to use the specific peptide for DDR2 as a ligand in similar assays. It was shown 
by other groups that cells will adhere to DDR2 specific peptide but will not spread due to lack of 
ligand for integrin engagement (Xu et al., 2012). If we still see integrin β1 activation and talin1 
recruitment in this context, it would show that DDR2 collagen binding is upstream of both, 
giving insight into the larger question of whether integrins bind ligand and are then bound by 
talin1 or vice versa.  
  Integrins are activated bidirectionally; outside – in through direct ligand engagement or 
inside – out downstream of signaling pathways which recruit and activate talin1. Regardless of 
route, integrins are not fully activated until they are bound by talin1 (Kim et al., 2011). We have 
shown here that DDR2 regulates integrin β1 activity without influencing the amount of integrin 
β1 in protrusions. We have further shown that DDR2 action stimulates Rap1-GTP activity, 
which is correlated to talin1 recruitment to adhesions. Talin1 can be activated by a few 
pathways, including downstream of PIP2(Martel et al., 2001), RIAM(Yang et al., 2014), 
Gα13(Schiemer et al., 2016), or Kank2 (Klapholz and Brown, 2017; Sun et al., 2016). These 
pathways may all depend upon one another or may only exist in one cell type. For example, in 
platelets, PIP2 and Gα13 are required for talin1 activation but RIAM is not (Schiemer et al., 
2016; Stritt et al., 2015). We do not yet know in CAFs which of or if these pathways are 
required. Experiments are under way now to test these questions.  
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 An interesting fact about integrins is that in vivo, ligand is constantly available for 
fibroblasts; collagen is one of the most highly expressed protein in the body. Some argue that in 
this setting, outside – in signaling trumps inside – out signaling simply due to stochastic 
availability of high affinity integrins (Klapholz and Brown, 2017). Our work here may suggest 
that inside – out signaling does play a large role in vivo as we see dramatic differences in ECM 
collagen alignment and stiffness in our system, though we still cannot say for certain that a 
DDR2 – integrin β1 activation pathway is the cause for the change. Future work will have to be 
done to conclusively link CAF integrin β1 activation and cellular contractility to changes in 
collagen architecture in vivo. Another way that integrins transduce force and strengthen 
adhesions is through increased avidity or clustering, a phenomenon which requires Kindlin2 
(Kahner et al., 2012; Montanez et al., 2008). It is not yet known whether DDR2 action plays a 
role in this process or if DDR2 affects Kindlin2 expression or localization. Experiments are 
under way now to test this possibility.  
 
Downstream signaling and regulation of DDR2 
 It is clear that DDR2 plays many roles in cancer and other diseases so it will continue to 
be important to discover the signaling pathways downstream of DDR2, both kinase dependent 
and independent. The Longmore lab has previously shown that DDR2 stabilizes the EMT factor 
Snail1. DDR2 activation by collagen led to the nuclear accumulation of Snail1 and protection 
from degradation in a src/ERK2 dependent manner. This stabilization was found to promote 
EMT and facilitate metastasis in a 4T1 transplant model of breast cancer (Zhang et al., 2013). 
The lab has gone on to show that Snail1 in CAFs is activated by mechanical signals and that this 
activation promotes fibrosis (Zhang et al., 2016). It is not yet known whether DDR2 signaling to 
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Snail1 is required for the pro-fibrotic phenotype. Further, it is not known whether Snail1 is 
required in CAFs for integrin β1 activation. The possibility, however, is unlikely as Snail1 is 
stabilized downstream of DDR2 activation, and we see effects on integrin β1 within 15 min. 
Other possible kinase dependent or independent pathways that have yet to be explored include 
crosstalk with other RTKs. Crosstalk between RTKs is common and can lead to differential 
effects of and resistance to treatment (Stommel et al., 2007), but no such phenotype has yet to be 
described for DDR2.  
 The activation kinetics of DDRs are extremely long, on the order of hours, and it is not 
entirely clear how it occurs. For both DDR1 and DDR2, it appears that Src must phosphorylate 
tyrosine residues in the activation loop for activation (Lu et al., 2011; Yang et al., 2005). For 
DDR1, there is evidence that the receptor is quickly internalized into endosomes after collagen 
stimulation but before it is fully activated. It is not clear if the ligand is retained or if there is 
some ‘memory’ of ligand binding (Mihai et al., 2009). It seems unlikely but not impossible that 
the receptor would be internalized with collagen peptides bound to it, a process which would 
require coordinated proteolysis of collagen fibers. It is not known whether DDR2 also undergoes 
receptor internalization after collagen stimulation, though the question is interesting. 
 Because the kinetics of DDR2 autophosphorylation and activation are so uncommon, 
research into other methods by which DDRs acts are emerging. Of these possibilities, clustering 
of the receptors into multimers seems to be the most likely. Clustering of receptors can have 
several effects, including the ability to form more contacts with ligand and to locally pool 
signaling partners near the membrane. DDR2 is known to interact with src as well as other 
proteins containing SH2 or PTB binding domains, however these interactions depend on tyrosine 
phosphorylation (Ikeda et al., 2002). It is not known whether DDR2 is capable of acting as a co-
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receptor for other transmembrane proteins or RTKs, nor it is known whether clustering itself 
recruits other proteins. DDR1 has been shown to cluster within minutes of collagen binding 
(Mihai et al., 2009), suggesting that clustering is a kinase independent function. Further, DDR1 
was recently shown to influence collagen contraction, and clustering as well as direct interaction 
with non-muscle myosin IIa (NMAII) was required, however they determined that the phenotype 
was kinase dependent (Coelho et al., 2017). It is possible that collagen binding creates clusters of 
DDR2 as well and that is how signaling downstream of DDR2 recruits talin1 and activates 
integrin β1in CAFs. Future studies could use the DDR2 W52A mutant to determine if collagen 
binding is required for clustering, and, further, use the new DDR2 T96/98A mutant (binds 
collagen but does not cluster) to determine if collagen binding is sufficient to activate integrin β1 
or if clustering is necessary. Collagen binding only could support a mechanism by which 
potential DDR2 conformational changes are required for kinase independent signaling. More 
research is needed to fully understand the kinase dependent and independent functions of DDRs.  
   
DDR2 in other cell types 
 The Longmore lab has now demonstrated roles for DDR2 action in multiple cell types in 
breast cancer metastasis. In initial studies, a DDR2 null mouse was used to assess whether there 
was a global defect in breast cancer metastasis related to DDR2 expression. In both a transplant 
and genetic MMTV-PyMT model of breast cancer, DDR2, in general, was found to be essential 
for lung metastasis (Corsa et al., 2016). DDR2 is not expressed on normal breast epithelial cells, 
but it is aberrantly expressed in 71% of invasive breast cancer tumor cells (Zhang et al., 2013), 
so studies first focused on DDR2 action in tumor cells. Using MMTV-Cre and K14-Cre, the 
luminal and basal epithelial cells were targeted in the MMTV-PyMT model. Analysis of end 
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stage animals showed that while luminal DDR2 expression was dispensable in lung metastasis, 
basal DDR2 expression was critical. Since K14+ basal cells are invasive and contractile, they 
went on to show that DDR2 expression in these cells was necessary for local invasion (Corsa et 
al., 2016). One potential complication with this study is that K14+ progenitors give rise to both 
the luminal and basal stem cell populations in normal breast development, so it possible that 
K14-Cre targets both the luminal and basal epithelial compartments (Visvader and Stingl, 2014). 
While it is clear through studies using MMTV-Cre that DDR2 in the luminal compartment alone 
is not sufficient to drive metastasis, it is not yet clear that DDR2 action in basal cells is sufficient. 
Further studies using an inducible K14-Cre could bypass developmental K14 expression in 
progenitors and restrict DDR2 deletion to the basal cells and basal progenitors. 
 This study utilizes FSP1-Cre to delete DDR2 from fibroblasts as efficiently as possible. 
Unfortunately, it is likely that FSP1-Cre also targets a subset of CD45+/F4/80+ macrophages. 
While we can correlate in vitro phenotypes to in vivo collagen derangements, we cannot say with 
absolute certainty that the reduction in lung metastasis is directly due to DDR2 expression in 
CAFs. Since CAFs are an extremely heterogeneous population with cells from multiple sources, 
it is unlikely that a Cre will ever be derived which selectively target CAFs. One experiment that 
remains to be done is a co-transplant mixing experiment where DDR2 +/- CAFs are co-injected 
with wild type and DDR2 null tumor cells into wild type and DDR2 null mice. This experiment, 
while imperfect, would allow interrogation of DDR2 in CAFs more specifically. 
 Systems in which DDR2 contribution to breast cancer metastasis have not yet been 
explored include the immune system and endothelial cells. DDR2 is expressed in some cells of 
the myeloid lineage including macrophages (Ferri et al., 2004), dendritic cells (Lee et al., 2007), 
and neutrophils (Afonso et al., 2013). In neutrophils, DDR2 expression was required for 3D 
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migration (Afonso et al., 2013). Immune cell contribution to cancer is profound, especially in the 
innate inflammatory response that is mediate by macrophages and neutrophils. Macrophages can 
be pro – or anti – tumorigenic depending on class (DeNardo et al., 2009; Zhu et al., 2014). 
Dendritic cells present antigen to the adaptive immune system, which modulates the T cell 
response (Quintana, 2017). The role for DDR2 in these cell types has not been explored, though 
Snail1 has been implicated as important for some immune cell functions. Since DDR2 is an 
upstream regulator of Snail1 (Zhang et al., 2013) and required in neutrophils for invasion, it may 
be involved in the innate immune response in cancer. Future studies could include using LysM-
Cre to delete DDR2 in macrophages and neutrophils in a genetic or transplant model of breast 
cancer, however the cell type specificity would still be low (Clausen et al., 1999). Reciprocal 
bone marrow transplants or specific implantation of modified immune cells could abrogate that 
problem.  
 Another important process necessary for metastasis is angiogenesis. In order for cells to 
escape the primary site, they must be able to enter the bloodstream or lymphatics. Blood vessels 
which develop in solid tumors under stimulation by growth factors such as VEGF are often 
disorganized and leaky, allowing easier intravasation of invading tumor cells (Kerbel, 2008). 
There is evidence that DDR2 expression is upregulated in tumor endothelial cells and that it 
plays a role in angiogenesis (Zhang et al., 2014). The authors in that study utilize a DDR2 global 
null mouse for their studies, so using a more Cre to more specifically target endothelial cell in a 
breast cancer model would be interesting. Further, there is increasing evidence that DDR2 
regulates VEGFR levels in endothelial cells, suggesting a possible mechanism by which DDR2 




DDR2 in downstream metastatic processes 
 The bulk of our work in describing the effect of DDR2 on breast cancer metastasis has 
focused on the primary site. In the primary site, tumors must invade away from the tumor core, 
through the tumor associated stroma, and intravasate into the blood stream or lymphatics. At this 
time, we cannot rule out a role for DDR2 in other steps of the metastatic cascade. We have 
shown that DDR2 depleted tumor cells do not grow in the lung as well as wild type cells in a tail 
vein injection model (unpublished, Corsa), however this experiment does not necessarily parse 
out whether the difference was due to problems with extravasation, seeding, or outgrowing in the 
lung. Lung colonization in this experiment was detected by bioluminescence, and no differences 
in initial lung photon flux were observed. This suggests that DDR2 depleted tumor cells could 
extravasate as efficiently as wild type. In other unpublished work from our lab, we have tail vein 
injected both wild type and DDR2 global null mice with wild type tumor and see no differences 
in lung tumor burden. This suggests that no intrinsic defect lies in the lungs of DDR2 global null 
mice that may explain differences in lung metastasis.  
 While we have mostly focused on lung metastasis in the Longmore lab, other sites of 
breast cancer metastasis are common in women, particularly the bone (American Cancer Society, 
Facts & Figures, 2017). DDR2 has profound effects on bone development and skeletal growth 
(Bargal et al., 2009; Ge et al., 2016), however no work has been done to determine if DDR2 
effects bone metastasis in breast cancer. Future studies could utilize existing models in the lab to 
determine if any differences in bone metastasis exist, and, if so, what mechanisms may underlie 




DDR2 in other cancers and diseases 
 DDR2 expression or mutation has been implicated in several cancers and diseases. 
Several mutations have been described for DDR2 in non-small cell lung cancer and squamous 
cell carcinoma of the lung (Hammerman et al., 2011; Rikova et al., 2007) as well as aberrant 
expression in ovarian cancer (Divine, et al, 2015), nasopharyngeal cancer (Chua et al., 2008), 
and aggressive thyroid cancer (Rodrigues et al., 2007). DDR2 has now been shown to have 
effects on collagen deposition and collagen remodeling, so it is likely that any cancer or 
pathology involving fibrosis may involve DDR2. Interestingly, in liver fibrosis, loss of DDR2 
was found to promote increased fibrosis in a model of carbon tetrachloride injury. The authors 
proposed that this effect was due to dysregulation of paracrine signaling between hepatic stellate 
cells and macrophages, suggesting that, in some cases, DDR2 action modulates or limits 
deposition of collagen (Olaso et al., 2011a). In other systems, it has been suggested that DDR2 
expression increases fibrosis, such as in a bleomycin induced model of lung fibrosis or alcoholic 
liver disease (Luo et al., 2013; Yang et al., 2013). It is clear that further work is required to tease 
out the relative contribution of DDR2 to fibrosis, and research in fibrotic cancers such as 
pancreatic cancer is warranted. 
 DDR2 mutation is a cause of dwarfism called SMED-SL, however no other collagen 
disorders have been associated with DDR2 expression or mutation (Bargal et al., 2009). 
However, DDR2 has been implicated in osteoarthritis (OA) where upregulation of the protein 
was found in chondrocytes in joints affected by OA. This upregulation caused increased 
expression and activity of MMP-13, enhancing the degradation of articular cartilages (Xu et al., 
2007; Xu et al., 2005). OA can develop due to genetic causes or from injury and surgery. In both 
cases, DDR2 expression and concomitant MMP-13 upregulation were observed in mice and 
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human patients (Sunk et al., 2007). While it is unknown how DDR2 upregulation occurs in 
articular cartilages, the seemingly consistent finding that MMP-13 upregulation associated with 
DDR2 expression makes the pathway a potential therapeutic target for OA.  
  
Therapeutic potential of targeting DDR2 
 Despite improvements in detection, diagnosis, and treatment, breast cancer metastasis 
remains the second leading cause of cancer related death in women in the United States 
(American Cancer Society). Developing treatments that specifically target the metastatic process, 
in addition to treating tumor growth itself, will be essential to reducing metastasis related death. 
Breast cancers are typically detected early, but 1 in 10 women will still develop metastasis within 
five years and 1 in 5 with ten years. We can now show that DDR2 regulates breast cancer 
metastasis in at least two different cell types, the basal epithelial cells (Corsa et al., 2016)and 
stromal cells expressing FSP1. These studies are one of the first to show potential efficacy for 
targeting a single protein in multiple compartments. If treatments targeting DDR2 make it 
through clinical trials, the ability to hit at least two pathways by which tumor cells metastasize 
can only increase the odds of treatment success. 
 While we have shown that DDR2 action in breast tumor and stromal cells is essential for 
metastasis, we do not show any effect of DDR2 on tumor growth or tumor latency. This would 
suggest that treatment of breast cancer with a DDR2 inhibitor alone would never be feasible. In 
practical terms, the tumor would likely be surgically removed and/or treated with other drugs 
such as immunotherapies or chemotherapy in addition to DDR2 inhibition. Hopefully by doing 
so, not only could we treat the tumor itself but also allay any downstream metastatic processes. It 
is currently unknown what effects DDR2 action may have on metastatic but dormant cells. More 
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work will need to be done in the future to determine if DDR2 inhibition would help treat 
metastatic recurrence.   
 Most cancers have mutations in receptor tyrosine kinases which promote cell growth and 
survival. For this reason, many tyrosine kinase inhibitors have been developed which target and 
inhibit the kinase domain of this class of receptors. However, the pitfalls of this strategy have 
been problems with specificity, toxicity, and development of resistance (Lin and Shaw, 2016; 
Zhu et al., 2011). DDR2 is unique in that it binds an insoluble substrate, fibrillar collagen 
(Shrivastava et al., 1997; Vogel et al., 1997), and the possibility exists that it may be possible to 
interfere with collagen binding rather than kinase activity. It would also allow for the 
development of compounds which do not need to enter the cell, which would improve selectivity 
and reduce toxicity. Importantly, there is new evidence that DDRs may have kinase independent 
functions that a kinase inhibitor would not affect (Hammerman et al., 2011). In this study, we 
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